(Exact Name of Registrant as Specified in Its Charter) |
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: | ||||
Title of Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |||
Emerging growth company | |||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Date: | November 8, 2019 | COLONY CAPITAL, INC. | |
By: | /s/ Mark M. Hedstrom | ||
Mark M. Hedstrom | |||
Chief Financial Officer, Chief Operating Officer and Treasurer |
• | Third quarter 2019 U.S. GAAP net loss attributable to common stockholders was $(555.0) million, or $(1.16) per share, and Core FFO was $101.6 million, or $0.19 per share; and for the nine months ended September 30, 2019, U.S. GAAP net loss attributable to common stockholders was $(1,126.0) million, or $(2.35) per share, and Core FFO was $218.7 million, or $0.42 per share |
• | Third quarter 2019 U.S. GAAP net loss notably included reductions of goodwill, impairments of real estate and provision for loan losses totaling $540.3 million for the Company's share, of which $387.0 million was attributable to the reduction of goodwill primarily as a result of the pending sale of the Company’s industrial investment management business and related real estate portfolio, and the decrease in management fees from Colony Credit Real Estate, Inc. (NYSE: CLNC) resulting from impairments related to its portfolio bifurcation, both of which are ongoing components of the Company’s strategic repositioning to simplify and establish the leading platform for digital real estate and infrastructure |
• | Excluding net losses of $4.4 million primarily related to net investment losses in Other Equity and Debt offset by the termination fee received from NorthStar Realty Europe Corp. (“NRE”), Core FFO was $106.0 million, or $0.20 per share; and for the nine months ended September 30, 2019, excluding net losses of $30.6 million, Core FFO was $249.3 million, or $0.48 per share |
• | The Company’s Board of Directors declared and paid a third quarter 2019 dividend of $0.11 per share to holders of Class A and B common stock |
• | During the third quarter 2019, the Company: |
• | Successfully combined with Digital Bridge Holdings, LLC ("DBH"), the premier investment manager dedicated to digital real estate and infrastructure for $329 million of cash and OP unit consideration. Marc C. Ganzi, who co-founded DBH and is its Chief Executive Officer, will become the Chief Executive Officer of the Company no sooner than the end of 2020 following a transition period and will lead the Company’s strategic repositioning in becoming the leading platform for digital real estate and infrastructure with Thomas J. Barrack, Jr., who will resume the sole position of Executive Chairman |
• | Completed the sale of NRE for $17.01 per share through which the Company received $96 million for its 11% ownership stake in NRE representing a net cash gain of approximately $22 million, or 30% above the Company’s cost basis, in addition to the remaining $65 million of the $70 million lump sum incentive and termination fee payment |
• | Entered into definitive agreements for the sale of the Company’s light industrial portfolio, including the related operating platform, for an aggregate $5.7 billion, which is anticipated to result in net cash sale proceeds of approximately $1.2 billion representing a net cash gain of approximately $450 million |
• | Completed the planned sales and/or monetization of $272 million of assets and net equity proceeds within the Other Equity and Debt segment, inclusive of the Company’s 11% equity interest in NRE; and for the nine months ended September 30, 2019, $651 million of assets within the Other Equity and Debt segment were sold or monetized resulting in net equity proceeds of $531 million |
• | Held the first closing of its fifth global real estate credit fund (the “Global Credit Fund”) with total capital commitments of $428 million, inclusive of capital commitments of $121 million from certain subsidiaries of the Company, which may decrease to no less than 5% of total commitments from total third party commitments to the Global Credit Fund |
• | Entered into a series of transactions effectively terminating and settling the Company's $2 billion notional interest rate swap in the aggregate amount of $365 million |
• | Subsequent to the third quarter 2019: |
• | The Company refinanced a £212 million loan on a U.K. portfolio of senior housing assets with an interest rate of LIBOR plus 4.25% with a new £223 million fully extended five-year loan with an interest rate of LIBOR plus 3.75%; this refinancing, along with previously completed refinancing transactions this year, addresses all material near-term healthcare real estate loan maturities |
• | The Company achieved approximately 80% of the expected total $50 to $55 million ($45 to $50 million on a cash basis) of the previously announced annual compensation and administrative cost savings on a run rate basis through various initiatives with the balance expected to be achieved before year-end 2019 |
• | CLNC announced the bifurcation of its assets into a portfolio of core investments (“Core Portfolio”) and a portfolio of legacy, non-strategic investments that will advance its strategic plan to focus on key real estate credit investments and asset management competencies |
• | In conjunction with its focus on its Core Portfolio, CLNC meaningfully reduced the undepreciated book value of its non-strategic assets to better reflect its market value and reset its annualized dividend from $1.74 per share to $1.20 per share, which is now fully covered by in-place Core Earnings from its Core Portfolio alone |
• | Further, the Company amended its management agreement with CLNC to make effective in the beginning of the fourth quarter 2019 the alignment of the fee base with the newly reduced book value, which results in a decrease in annual base management fees from $45 million to $33 million |
• | The liquidation of legacy, non-strategic investments and capital redeployment into the Core Portfolio, combined with the reduced management fee, are expected to increase CLNC’s Core Earnings and narrow the discount between CLNC’s share price and book value, of which the Company’s 36% interest represents approximately $850 million of undepreciated book value |
• | The Company delivered a non-binding letter to the independent directors of CLNC seeking to explore with CLNC the possible internalization of its management agreement and a transfer of the Company’s private credit investment management business to CLNC to (i) further the Company’s strategic repositioning to simplify and establish the leading platform for digital real estate and infrastructure and (ii) position CLNC to become a leading independent real estate credit REIT with a clearly defined strategy positioned for greater growth |
• | As of November 5, 2019, the Company had approximately $620 million of liquidity through availability under its revolving credit facility and cash-on-hand |
Consolidated | CLNY OP | Same Store | ||||||||||||||||||||
NOI | Share NOI(1) | Consolidated NOI | Occupancy %(2) | TTM Lease Coverage(3) | ||||||||||||||||||
($ in millions) | Q3 2019 | Q3 2019 | Q3 2019 | Q2 2019 | Q3 2019 | Q2 2019 | 6/30/19 | 3/31/19 | ||||||||||||||
Senior Housing - Operating | $ | 15.6 | $ | 11.1 | $ | 15.6 | $ | 16.4 | 85.3 | % | 84.8 | % | N/A | N/A | ||||||||
Medical Office Buildings (MOB) | 12.9 | 9.1 | 12.9 | 13.5 | 82.2 | % | 82.1 | % | N/A | N/A | ||||||||||||
Triple-Net Lease: | ||||||||||||||||||||||
Senior Housing | 14.1 | 10.0 | 14.1 | 15.3 | 80.5 | % | 80.9 | % | 1.2x | 1.3x | ||||||||||||
Skilled Nursing Facilities | 25.5 | 18.1 | 23.4 | 24.2 | 82.5 | % | 83.3 | % | 1.2x | 1.2x | ||||||||||||
Hospitals | 3.2 | 2.3 | 3.2 | 5.0 | 58.3 | % | 63.4 | % | 2.7x | 2.4x | ||||||||||||
Healthcare Total | $ | 71.3 | $ | 50.6 | $ | 69.2 | $ | 74.4 |
(1) | CLNY OP Share NOI represents third quarter 2019 Consolidated NOI multiplied by CLNY OP’s ownership interest as of September 30, 2019. |
(2) | Occupancy % for Senior Housing - Operating represents average during the presented quarter, for MOB’s represents as of last day in the quarter and for other types represents average during the prior quarter. |
(3) | Represents the ratio of the tenant’s/operator’s EBITDAR to cash rent payable to the Company’s Healthcare Real Estate segment on a trailing twelve month basis. |
Consolidated | CLNY OP | Same Store | |||||||||||||||||
NOI | Share NOI (1) | Consolidated NOI | Leased %(2) | ||||||||||||||||
($ in millions) | Q3 2019 | Q3 2019 | Q3 2019 | Q2 2019 | 9/30/19 | 6/30/19 | |||||||||||||
Light Industrial | $ | 63.3 | $ | 21.2 | $ | 43.1 | $ | 42.2 | 95.0 | % | 94.5 | % | |||||||
Bulk Industrial | 3.5 | 1.8 | 3.5 | 3.0 | 67.4 | % | 67.4 | % | |||||||||||
Total Industrial | $ | 66.8 | $ | 23.0 |
(1) | CLNY OP Share NOI represents third quarter 2019 Consolidated NOI multiplied by CLNY OP’s ownership interest as of September 30, 2019. |
(2) | Leased % as of the reported date represents square feet under executed leases, some of which may not have taken occupancy. |
Same Store | |||||||||||||||||||||||||||||||||
Consolidated | CLNY OP Share | Consolidated | Avg. Daily Rate | RevPAR(3) | |||||||||||||||||||||||||||||
NOI before FF&E Reserve(1) | NOI before FF&E Reserve(2) | NOI before FF&E Reserve | Occupancy %(4) | (In dollars)(4) | (In dollars)(4) | ||||||||||||||||||||||||||||
($ in millions) | Q3 2019 | Q3 2019 | Q3 2019 | Q3 2018 | Q3 2019 | Q3 2018 | Q3 2019 | Q3 2018 | Q3 2019 | Q3 2018 | |||||||||||||||||||||||
Marriott | $ | 40.1 | $ | 37.7 | $ | 57.0 | $ | 57.2 | 77.4 | % | 77.8 | % | $ | 130 | $ | 130 | $ | 101 | $ | 101 | |||||||||||||
Hilton | 34.2 | 32.1 | 15.4 | 13.6 | 83.7 | % | 84.8 | % | 133 | 132 | 111 | 112 | |||||||||||||||||||||
Other | 3.1 | 2.9 | 4.8 | 4.6 | 86.6 | % | 85.4 | % | 139 | 139 | 120 | 118 | |||||||||||||||||||||
Total/W.A. | $ | 77.4 | $ | 72.7 | $ | 77.2 | $ | 75.4 | 79.0 | % | 79.4 | % | $ | 131 | $ | 131 | $ | 104 | $ | 104 |
(1) | Third quarter 2019 consolidated FF&E reserve was $9.4 million. |
(2) | CLNY OP Share NOI before FF&E Reserve represents third quarter 2019 Consolidated NOI before FF&E Reserve multiplied by CLNY OP’s ownership interest as of September 30, 2019. |
(3) | RevPAR, or revenue per available room, represents a hotel's total guestroom revenue divided by the room count and the number of days in the period being measured. |
(4) | For each metric, data represents average during the presented quarter. |
CLNY OP Share | |||||||||||||||
Undepreciated Carrying Value | |||||||||||||||
September 30, 2019 | June 30, 2019 | ||||||||||||||
($ in millions) | Assets | Equity | Assets | Equity | |||||||||||
Strategic: | |||||||||||||||
GP co-investments | $ | 1,145 | $ | 663 | $ | 1,176 | $ | 707 | |||||||
Interest in NRE | — | — | 87 | 87 | |||||||||||
Strategic Subtotal | 1,145 | 663 | 1,263 | 794 | |||||||||||
Non-Strategic: | |||||||||||||||
Other Real Estate Equity & Albertsons | 1,185 | 546 | 1,285 | 596 | |||||||||||
Real Estate Debt | 244 | 244 | 274 | 274 | |||||||||||
Net Lease Real Estate Equity | 184 | 80 | 184 | 77 | |||||||||||
CRE Securities and Real Estate Private Equity Funds | 65 | 65 | 67 | 67 | |||||||||||
Non-Strategic Subtotal | 1,678 | 935 | 1,810 | 1,014 | |||||||||||
Total Other Equity and Debt | $ | 2,823 | $ | 1,598 | $ | 3,073 | $ | 1,808 |
September 30, 2019 | June 30, 2019 | ||||||||||||
($ in billions) | Amount | % of Grand Total | Amount | % of Grand Total | |||||||||
Balance Sheet (CLNY OP Share): | |||||||||||||
Healthcare | $ | 3.7 | 6.9 | % | $ | 3.9 | 9.0 | % | |||||
Industrial | 1.7 | 3.2 | % | 1.7 | 3.9 | % | |||||||
Hospitality | 3.8 | 7.1 | % | 3.9 | 9.0 | % | |||||||
Other Equity and Debt | 2.8 | 5.3 | % | 3.1 | 7.2 | % | |||||||
CLNC(1) | 2.0 | 3.8 | % | 2.1 | 4.8 | % | |||||||
Balance Sheet Subtotal | 14.0 | 26.3 | % | 14.7 | 33.9 | % | |||||||
Investment Management: | |||||||||||||
Digital Bridge Holdings(2) | 13.8 | 25.9 | % | 1.9 | 4.4 | % | |||||||
Institutional Funds | 10.6 | 19.9 | % | 10.2 | 23.6 | % | |||||||
Colony Credit Real Estate (NYSE:CLNC)(3) | 3.5 | 6.6 | % | 3.7 | 8.5 | % | |||||||
Retail Companies | 3.4 | 6.4 | % | 3.4 | 7.9 | % | |||||||
NorthStar Realty Europe (NYSE:NRE) | — | — | % | 1.5 | 3.5 | % | |||||||
Non-Wholly Owned REIM Platforms(4) | 8.0 | 14.9 | % | 7.9 | 18.2 | % | |||||||
Investment Management Subtotal | 39.3 | 73.7 | % | 28.6 | 66.1 | % | |||||||
Grand Total | $ | 53.3 | 100.0 | % | $ | 43.3 | 100.0 | % |
(1) | Represents the Company’s 36% ownership share of CLNC’s total pro-rata share of assets of $5.6 and $5.8 billion as of September 30, 2019 and June 30, 2019, respectively. |
(2) | Second quarter 2019 reflects 50% of Digital Colony Partners AUM which in previous quarters was included in Non-Wholly Owned REIM Platforms. |
(3) | Represents third-party 64% ownership share of CLNC’s total pro-rata share of assets of $5.6 and $5.8 billion as of September 30, 2019 and June 30, 2019, respectively. |
(4) | REIM: Real Estate Investment Management |
September 30, 2019 | December 31, 2018 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 455,330 | $ | 461,912 | ||||
Restricted cash | 257,435 | 364,605 | ||||||
Real estate, net | 9,722,420 | 10,826,010 | ||||||
Loans receivable, net | 1,454,199 | 1,659,217 | ||||||
Equity and debt investments | 2,291,121 | 2,529,747 | ||||||
Goodwill | 1,374,809 | 1,514,561 | ||||||
Deferred leasing costs and intangible assets, net | 438,365 | 445,930 | ||||||
Assets held for sale | 5,560,203 | 3,967,345 | ||||||
Other assets | 516,964 | 400,143 | ||||||
Due from affiliates | 53,148 | 45,779 | ||||||
Total assets | $ | 22,123,994 | $ | 22,215,249 | ||||
Liabilities | ||||||||
Debt, net | $ | 8,666,108 | $ | 8,975,372 | ||||
Accrued and other liabilities | 923,432 | 634,144 | ||||||
Intangible liabilities, net | 95,502 | 147,470 | ||||||
Liabilities related to assets held for sale | 2,334,643 | 1,218,495 | ||||||
Due to affiliates | 36,285 | — | ||||||
Dividends and distributions payable | 86,588 | 84,013 | ||||||
Total liabilities | 12,142,558 | 11,059,494 | ||||||
Commitments and contingencies | ||||||||
Redeemable noncontrolling interests | 5,987 | 9,385 | ||||||
Equity | ||||||||
Stockholders’ equity: | ||||||||
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding | 1,407,495 | 1,407,495 | ||||||
Common stock, $0.01 par value per share | ||||||||
Class A, 949,000 shares authorized; 487,018 and 483,347 shares issued and outstanding, respectively | 4,871 | 4,834 | ||||||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | 7 | 7 | ||||||
Additional paid-in capital | 7,538,356 | 7,598,019 | ||||||
Distributions in excess of earnings | (3,307,886 | ) | (2,018,302 | ) | ||||
Accumulated other comprehensive income | 20,888 | 13,999 | ||||||
Total stockholders’ equity | 5,663,731 | 7,006,052 | ||||||
Noncontrolling interests in investment entities | 3,855,334 | 3,779,728 | ||||||
Noncontrolling interests in Operating Company | 456,384 | 360,590 | ||||||
Total equity | 9,975,449 | 11,146,370 | ||||||
Total liabilities, redeemable noncontrolling interests and equity | $ | 22,123,994 | $ | 22,215,249 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Revenues | ||||||||||||||||
Property operating income | $ | 462,155 | $ | 494,945 | $ | 1,409,841 | $ | 1,500,991 | ||||||||
Interest income | 40,237 | 59,883 | 121,362 | 167,326 | ||||||||||||
Fee income | 111,854 | 32,915 | 178,315 | 106,733 | ||||||||||||
Other income | 38,249 | 10,984 | 64,475 | 35,762 | ||||||||||||
Total revenues | 652,495 | 598,727 | 1,773,993 | 1,810,812 | ||||||||||||
Expenses | ||||||||||||||||
Property operating expense | 274,351 | 286,386 | 824,333 | 871,536 | ||||||||||||
Interest expense | 130,034 | 134,245 | 406,661 | 415,397 | ||||||||||||
Investment and servicing expense | 13,096 | 11,076 | 51,562 | 55,546 | ||||||||||||
Transaction costs | 100 | 228 | 2,922 | 3,585 | ||||||||||||
Placement fees | 64 | 5,184 | 373 | 6,477 | ||||||||||||
Depreciation and amortization | 159,005 | 111,807 | 379,739 | 331,981 | ||||||||||||
Provision for loan loss | 17,233 | 7,825 | 35,847 | 27,133 | ||||||||||||
Impairment loss | 564,899 | 75,723 | 675,216 | 298,781 | ||||||||||||
Compensation expense | ||||||||||||||||
Cash and equity-based compensation | 87,043 | 44,469 | 160,990 | 144,085 | ||||||||||||
Carried interest and incentive fee compensation | 10,846 | 1,535 | 13,264 | 1,535 | ||||||||||||
Administrative expenses | 22,013 | 22,421 | 64,544 | 69,390 | ||||||||||||
Total expenses | 1,278,684 | 700,899 | 2,615,451 | 2,225,446 | ||||||||||||
Other income (loss) | ||||||||||||||||
Gain on sale of real estate assets | 8,224 | 33,016 | 43,754 | 91,869 | ||||||||||||
Other gain (loss), net | (44,562 | ) | 29,677 | (183,137 | ) | 133,731 | ||||||||||
Equity method earnings (losses) | 46,777 | 5,031 | (178,448 | ) | 34,338 | |||||||||||
Equity method earnings (losses)—carried interest | (474 | ) | 3,837 | 6,258 | 3,837 | |||||||||||
Loss before income taxes | (616,224 | ) | (30,611 | ) | (1,153,031 | ) | (150,859 | ) | ||||||||
Income tax benefit (expense) | (9,968 | ) | 1,955 | (13,751 | ) | 35,279 | ||||||||||
Loss from continuing operations | (626,192 | ) | (28,656 | ) | (1,166,782 | ) | (115,580 | ) | ||||||||
Income from discontinued operations | 60,350 | 11,242 | 86,139 | 28,100 | ||||||||||||
Net loss | (565,842 | ) | (17,414 | ) | (1,080,643 | ) | (87,480 | ) | ||||||||
Net income (loss) attributable to noncontrolling interests: | ||||||||||||||||
Redeemable noncontrolling interests | 364 | 865 | 2,317 | 2,042 | ||||||||||||
Investment entities | 15,170 | 28,914 | 51,744 | 74,517 | ||||||||||||
Operating Company | (53,560 | ) | (4,403 | ) | (90,160 | ) | (14,509 | ) | ||||||||
Net loss attributable to Colony Capital, Inc. | (527,816 | ) | (42,790 | ) | (1,044,544 | ) | (149,530 | ) | ||||||||
Preferred stock redemption | — | — | — | (3,995 | ) | |||||||||||
Preferred stock dividends | 27,137 | 27,185 | 81,412 | 89,960 | ||||||||||||
Net loss attributable to common stockholders | $ | (554,953 | ) | $ | (69,975 | ) | $ | (1,125,956 | ) | $ | (235,495 | ) | ||||
Basic loss per share | ||||||||||||||||
Loss from continuing operations per basic common share | $ | (1.22 | ) | $ | (0.16 | ) | $ | (2.43 | ) | $ | (0.50 | ) | ||||
Net loss per basic common share | $ | (1.16 | ) | $ | (0.15 | ) | $ | (2.35 | ) | $ | (0.47 | ) | ||||
Diluted loss per share | ||||||||||||||||
Loss from continuing operations per diluted common share | $ | (1.22 | ) | $ | (0.16 | ) | $ | (2.43 | ) | $ | (0.50 | ) | ||||
Net loss per diluted common share | $ | (1.16 | ) | $ | (0.15 | ) | $ | (2.35 | ) | $ | (0.47 | ) | ||||
Weighted average number of shares | ||||||||||||||||
Basic | 479,776 | 484,754 | 479,412 | 501,202 | ||||||||||||
Diluted | 479,776 | 484,754 | 479,412 | 501,202 |
Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2019 | |||||||
Net loss attributable to common stockholders | $ | (554,953 | ) | $ | (1,125,956 | ) | ||
Adjustments for FFO attributable to common interests in Operating Company and common stockholders: | ||||||||
Net loss attributable to noncontrolling common interests in Operating Company | (53,560 | ) | (90,160 | ) | ||||
Real estate depreciation and amortization | 116,615 | 430,513 | ||||||
Impairment of real estate | 177,900 | 291,122 | ||||||
Gain from sales of real estate | (12,928 | ) | (75,250 | ) | ||||
Less: Adjustments attributable to noncontrolling interests in investment entities | (67,498 | ) | (191,477 | ) | ||||
FFO attributable to common interests in Operating Company and common stockholders | (394,424 | ) | (761,208 | ) | ||||
Additional adjustments for Core FFO attributable to common interests in Operating Company and common stockholders: | ||||||||
Gains and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO (1) | (39,959 | ) | (47,809 | ) | ||||
Gains and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment | 387,000 | 409,420 | ||||||
CLNC Core Earnings & NRE Cash Available for Distribution adjustments (2) | 5,063 | 269,108 | ||||||
Equity-based compensation expense | 11,590 | 28,328 | ||||||
Straight-line rent revenue and expense | (466 | ) | (12,727 | ) | ||||
Amortization of acquired above- and below-market lease values, net | (3,569 | ) | (10,893 | ) | ||||
Amortization of deferred financing costs and debt premiums and discounts | 16,158 | 59,156 | ||||||
Unrealized fair value losses on interest rate and foreign currency hedges, and foreign currency remeasurements and realized gains and losses on interest rate hedging instruments existing at the time of the January 2017 merger with remaining terms greater than one year that served as economic hedges for any financing or refinancing of the Company's real estate verticals | 93,322 | 240,598 | ||||||
Acquisition and merger-related transaction costs | 101 | 4,279 | ||||||
Restructuring and merger integration costs (3) | 18,592 | 19,722 | ||||||
Amortization and impairment of investment management intangibles | 65,158 | 80,731 | ||||||
Non-real estate depreciation and amortization | 1,588 | 4,730 | ||||||
Gain on consolidation of equity method investment | (51,400 | ) | (51,400 | ) | ||||
Amortization of gain on remeasurement of consolidated investment entities | — | 3,807 | ||||||
Tax effect of Core FFO adjustments, net | (5,500 | ) | (10,367 | ) | ||||
Less: Adjustments attributable to noncontrolling interests in investment entities | (1,653 | ) | (6,787 | ) | ||||
Core FFO attributable to common interests in Operating Company and common stockholders | $ | 101,601 | $ | 218,688 | ||||
FFO per common share / common OP unit (4) | $ | (0.74 | ) | $ | (1.46 | ) | ||
FFO per common share / common OP unit—diluted (4)(5) | $ | (0.74 | ) | $ | (1.46 | ) | ||
Core FFO per common share / common OP unit (4) | $ | 0.19 | $ | 0.42 | ||||
Core FFO per common share / common OP unit—diluted (4)(5)(6) | $ | 0.19 | $ | 0.42 | ||||
Weighted average number of common OP units outstanding used for FFO and Core FFO per common share and OP unit (4) | 534,772 | 522,650 | ||||||
Weighted average number of common OP units outstanding used for FFO per common share and OP unit—diluted (4)(5) | 534,772 | 522,650 | ||||||
Weighted average number of common OP units outstanding used for Core FFO per common share and OP unit—diluted (4)(5)(6) | 562,709 | 525,200 |
(1) | For the three months ended September 30, 2019, net of $47.4 million consolidated or $41.8 million CLNY OP share and for the nine months ended September 30, 2019, net of $93.9 million consolidated or $67.1 million CLNY OP share of depreciation, amortization and impairment charges previously adjusted to calculate FFO. |
(2) | Represents adjustments to align the Company’s Core FFO with CLNC’s definition of Core Earnings and NRE’s definition of Cash Available for Distribution (“CAD”) to reflect the Company’s percentage interest in the respective company’s earnings. |
(3) | Restructuring and merger integration costs primarily represent costs and charges incurred as a result of the corporate restructuring and reorganization plan announced in November 2018. Also included to a lesser degree are costs and charges related to the implementation of our strategic plan including the sale of the Industrial business. These integration and restructuring costs are not reflective of the Company’s core operating performance and the Company does not expect to incur these costs subsequent to the completion of the corporate restructuring and reorganization plan and the strategic plan. The majority of these costs consist of severance, employee costs of those separated or scheduled for separation, system integration and lease terminations. |
(4) | Calculated based on weighted average shares outstanding including participating securities and assuming the exchange of all common OP units outstanding for common shares. |
(5) | For the three months ended September 30, 2019, included in the calculation of diluted Core FFO per share is the effect of adding back $4.4 million of interest expense associated with convertible senior notes and 25.4 million of weighted average dilutive common share equivalents for the assumed conversion of the convertible senior notes. For the nine months ended September 30, 2019, included in the calculation of diluted Core FFO per share is the effect of adding back $0.5 million of interest expense associated with convertible senior notes and 1.1 million of weighted average dilutive common share equivalents for the assumed conversion of the convertible senior notes. For the three months and nine months ended September 30, 2019, such interest expense and weighted average dilutive common share equivalents are excluded for the calculation of diluted FFO as the effect would be antidilutive. |
(6) | For the three months ended September 30, 2019, included in the calculation of diluted Core FFO per share are 2,451,400 weighted average performance stock units, which are subject to both a service condition and market condition, and 67,300 weighted average shares of non-participating restricted stock. For the nine months ended September 30, 2019, included in the calculation of diluted Core FFO per share are 1,320,900 weighted average performance stock units, which are subject to both a service condition and market condition, and 99,100 weighted average shares of non-participating restricted stock. |
Three Months Ended September 30, 2019 | ||||||||||||
(In thousands) | Healthcare | Industrial(1) | Hospitality | |||||||||
Total revenues | $ | 136,091 | $ | 98,642 | $ | 218,378 | ||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | 1,235 | (4,518 | ) | 314 | ||||||||
Interest income | — | (240 | ) | — | ||||||||
Other income | — | — | (69 | ) | ||||||||
Property operating expenses (2) | (66,042 | ) | (26,051 | ) | (141,235 | ) | ||||||
Compensation and administrative expense (2) | — | (1,042 | ) | — | ||||||||
NOI(3) | $ | 71,284 | $ | 66,791 | $ | 77,388 |
(1) | Industrial financial results are classified as discontinued operations on the Company's consolidated statement of operations for the three months ended September 30, 2019. |
(2) | For healthcare and hospitality, property operating expenses include property management fees paid to third parties. For industrial, there are direct costs of managing the portfolio which are included in compensation expense. |
(3) | For hospitality, NOI is before FF&E Reserve. |
Three Months Ended September 30, 2019 | ||||||||||||
(In thousands) | Healthcare | Industrial(1) | Hospitality | |||||||||
Net income (loss) | $ | (112,554 | ) | $ | 38,981 | $ | (34,365 | ) | ||||
Adjustments: | ||||||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | 1,235 | (4,518 | ) | 314 | ||||||||
Interest income | — | (240 | ) | — | ||||||||
Interest expense | 46,029 | 21,130 | 40,641 | |||||||||
Transaction, investment and servicing costs | 1,009 | 54 | 1,728 | |||||||||
Depreciation and amortization | 38,998 | 12,342 | 36,133 | |||||||||
Impairment loss | 92,885 | — | 31,555 | |||||||||
Compensation and administrative expense | 2,537 | 3,832 | 1,658 | |||||||||
Gain on sale of real estate | (833 | ) | (4,675 | ) | — | |||||||
Other (gain) loss, net | 2,544 | 12 | 37 | |||||||||
Other income | — | — | (69 | ) | ||||||||
Income tax (benefit) expense | (566 | ) | (127 | ) | (244 | ) | ||||||
NOI(2) | $ | 71,284 | $ | 66,791 | $ | 77,388 |
(1) | Industrial financial results are classified as discontinued operations on the Company's consolidated statement of operations for the three months ended September 30, 2019. |
(2) | For hospitality, NOI is before FF&E Reserve. |
(In thousands) | Net Income (Loss) | ||||
Healthcare | $ | (112,554 | ) | ||
Industrial | 38,981 | ||||
Hospitality | (34,365 | ) | |||
CLNC | 7,979 | ||||
Other Equity and Debt | (5,160 | ) | |||
Investment Management | (316,302 | ) | |||
Amounts Not Allocated to Segments | (144,421 | ) | |||
Total Consolidated | $ | (565,842 | ) |
Cautionary Statement Regarding Forward-Looking Statements |
Colony Capital | Supplemental Financial Report |
Important Note Regarding Non-GAAP Financial Measures |
Colony Capital | Supplemental Financial Report |
Important Note Regarding Non-GAAP Financial Measures |
Colony Capital | Supplemental Financial Report |
Note Regarding CLNY Reportable Segments / Consolidated and OP Share of Consolidated Amounts |
Colony Capital | Supplemental Financial Report |
Table of Contents |
Page | |||
I. | 6-15 | ||
II. | Financial Overview | ||
a. | 16 | ||
b. | 17-18 | ||
III. | Financial Results | ||
a. | 19 | ||
b. | 20 | ||
c. | 21 | ||
d. | 22 | ||
e. | 23 | ||
IV. | Capitalization | ||
a. | 24 | ||
b. | 25 | ||
c. | 26 | ||
d. | 27 | ||
e. | 28 | ||
V. | Healthcare Real Estate | ||
a. | 29 | ||
b. | 30-31 | ||
VI. | Industrial Real Estate | ||
a. | 32 | ||
b. | 33 | ||
Page | |||
VII. | Hospitality Real Estate | ||
a. | 34 | ||
b. | 35 | ||
VIII. | CLNC | ||
a. | 36 | ||
IX. | 37 | ||
a. | 38 | ||
b. | 39 | ||
c. | 40-42 | ||
d. | 43 | ||
X. | Investment Management | ||
a. | 44-45 | ||
b. | 46 | ||
XI. | Appendices | ||
a. | 48-49 | ||
b. | 50-51 | ||
c. | Industrial Real Estate - Held for Sale and Discontinued Operations | 52-53 | |
Colony Capital | Supplemental Financial Report | 5 |
Colony Capital | Supplemental Financial Report | 6 |
Colony Capital | Supplemental Financial Report | 7 |
Colony Capital | Supplemental Financial Report | 8 |
Colony Capital | Supplemental Financial Report | 9 |
Colony Capital | Supplemental Financial Report | 10 |
Colony Capital | Supplemental Financial Report | 11 |
Colony Capital | Supplemental Financial Report | 12 |
Colony Capital | Supplemental Financial Report | 13 |
Colony Capital | Supplemental Financial Report | 14 |
Colony Capital | Supplemental Financial Report | 15 |
IIa. Financial Overview - Summary Metrics |
($ and shares in thousands, except per share data and as noted; as of or for the three months ended September 30, 2019, unless otherwise noted) (Unaudited) | |||
Financial Data | |||
Net income (loss) attributable to common stockholders | $ | (554,953 | ) |
Net income (loss) attributable to common stockholders per basic share | (1.16 | ) | |
Core FFO(1) | 101,601 | ||
Core FFO per basic share | 0.19 | ||
Q4 2019 dividend per share | 0.11 | ||
Annualized Q4 2019 dividend per share | 0.44 | ||
Balance Sheet, Capitalization and Trading Statistics | |||
Total consolidated assets | $ | 22,123,994 | |
CLNY OP share of consolidated assets | 14,618,345 | ||
Total consolidated debt(2) | 10,998,210 | ||
CLNY OP share of consolidated debt(2) | 7,580,173 | ||
Shares and OP units outstanding as of September 30, 2019(3) | 540,401 | ||
Shares and OP units outstanding as of November 5, 2019(3) | 540,398 | ||
Share price as of November 5, 2019 | 5.48 | ||
Market value of common equity & OP units as of November 5, 2019 | 2,961,381 | ||
Liquidation preference of perpetual preferred equity | 1,436,605 | ||
Insider ownership of shares and OP units as of November 5, 2019 | 9.4 | % | |
Total Assets Under Management ("AUM") | $ 53.3 billion | ||
Fee Earning Equity Under Management ("FEEUM") | $ 22.4 billion |
(1) | Third quarter 2019 Core FFO included net losses of $4.4 million. |
(2) | Represents principal balance and excludes debt issuance costs, discounts and premiums. |
(3) | Includes 21.5 million operating company units issued on July 25, 2019 for the acquisition of Digital Bridge Holdings. |
Colony Capital | Supplemental Financial Report | 16 |
IIb. Financial Overview - Summary of Segments |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | |||||
Healthcare Real Estate | |||||||
Q3 2019 net operating income(1)(2) | $ | 71,284 | $ | 50,586 | |||
Annualized net operating income | 285,136 | 202,161 | |||||
Investment-level non-recourse financing(3) | 2,953,705 | 2,108,463 | |||||
Industrial Real Estate | |||||||
Q3 2019 net operating income(2) | 66,791 | 23,018 | |||||
Annualized net operating income | 267,164 | 92,072 | |||||
Investment-level non-recourse financing(3) | 2,149,494 | 762,316 | |||||
Hospitality Real Estate | |||||||
Q3 2019 NOI before FF&E Reserve(2) | 77,388 | 72,667 | |||||
TTM NOI before FF&E Reserve(4) | 283,035 | 266,593 | |||||
Investment-level non-recourse financing(3) | 2,659,615 | 2,488,740 |
(1) | NOI includes $1.0 million consolidated or $0.7 million CLNY OP share of interest earned related to $54 million consolidated or $38 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended September 30, 2019. |
(2) | For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
(3) | Represents unpaid principal balance. |
(4) | TTM = trailing twelve month. |
Colony Capital | Supplemental Financial Report | 17 |
IIb. Financial Overview - Summary of Segments (cont’d) |
($ in thousands except as noted; as of or for the three months ended September 30, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
CLNC | ||||||||
Net carrying value of 36% interest | $ | 731,306 | $ | 731,306 | ||||
Other Equity and Debt (1) | ||||||||
1) Strategic Investments | ||||||||
a) GP co-investments - net carrying value | 1,909,472 | 662,808 | ||||||
2) Net lease real estate equity | ||||||||
a) Q3 2019 net operating income | 1,092 | 1,088 | ||||||
b) Investment-level non-recourse financing(2) | 104,821 | 104,198 | ||||||
3) Other real estate equity | ||||||||
a) Undepreciated carrying value of real estate assets(3) | 1,889,675 | 946,562 | ||||||
b) Investment-level non-recourse financing(2) | 1,278,448 | 638,835 | ||||||
c) Carrying value - equity method investments (including Albertsons) | 317,465 | 238,031 | ||||||
4) Real estate debt | ||||||||
a) Carrying value - consolidated(4) | 290,547 | 207,626 | ||||||
b) Investment-level non-recourse financing(2) | — | — | ||||||
c) Carrying value - equity method investments | 15,130 | 10,061 | ||||||
d) Carrying value - real estate assets (REO within debt portfolio) and other(3) | 45,397 | 26,029 | ||||||
5) CRE securities and real estate PE fund investments | ||||||||
a) Carrying value | 65,387 | |||||||
Investment Management | ||||||||
Third-party AUM ($ in millions) | 39,311 | |||||||
FEEUM ($ in millions)(5) | 22,411 | |||||||
Q3 2019 fee revenue and REIM platform equity method earnings(6) | 116,393 | |||||||
Net Assets | ||||||||
Cash and cash equivalents, restricted cash and other assets(7) | 1,239,317 | 985,125 | ||||||
Accrued and other liabilities and dividends payable(8) | 852,330 | 716,974 | ||||||
Net assets | $ | 386,987 | $ | 268,151 |
(1) | Includes assets classified as held for sale on the Company’s financial statements. |
(2) | Represents unpaid principal balance. |
(3) | Includes all components related to real estate assets, including tangible real estate and lease-related intangibles, and excludes accumulated depreciation. |
(4) | Excludes $54 million consolidated or $38 million CLNY OP share carrying value of healthcare real estate development loans. |
(5) | Subsequent to the third quarter 2019, the Company and CLNC revised the terms of the management agreement in connection with CLNC's portfolio bifurcation and related impairments, which will result in the reduction of the fee base by accumulated unrealized provisions for loan losses and real estate impairments. Such reduction will be effective during the fourth quarter 2019 and result in the decrease of the Company's FEEUM to $2.2 billion. |
(6) | The Company acquired Digital Bridge Holdings on July 25, 2019 and recognized incremental fee revenue of $14 million for the period between July 26, 2019 through September 30, 2019. Fee revenue also includes a $43 million termination fee and $22 million incentive fee resulting from the termination of the Company’s management agreement with NRE. Refer to page 44 for additional details. |
(7) | Other assets excludes $4 million consolidated and CLNY OP share of deferred financing costs and $40 million consolidated or $22 million CLNY OP share of restricted cash which is included in the undepreciated carrying value of the hotel portfolio in Other Real Estate Equity shown on page 39. |
(8) | Accrued and other liabilities exclude $37 million consolidated and CLNY OP share of deferred tax liabilities and other liabilities which are not due in cash and $121 million of derivative liability which is included in the debt of Other GP Co-investments shown on page 38. |
Colony Capital | Supplemental Financial Report | 18 |
IIIa. Financial Results - Consolidated Balance Sheet |
($ in thousands, except per share data) (unaudited) | As of September 30, 2019 | |||
Assets | ||||
Cash and cash equivalents | $ | 455,330 | ||
Restricted cash | 257,435 | |||
Real estate, net | 9,722,420 | |||
Loans receivable, net | 1,454,199 | |||
Equity and debt investments | 2,291,121 | |||
Goodwill | 1,374,809 | |||
Deferred leasing costs and intangible assets, net | 438,365 | |||
Assets held for sale | 5,560,203 | |||
Other assets | 516,964 | |||
Due from affiliates | 53,148 | |||
Total assets | $ | 22,123,994 | ||
Liabilities | ||||
Debt, net | $ | 8,666,108 | ||
Accrued and other liabilities | 923,432 | |||
Intangible liabilities, net | 95,502 | |||
Liabilities related to assets held for sale | 2,334,643 | |||
Due to affiliates | 36,285 | |||
Dividends and distributions payable | 86,588 | |||
Total liabilities | 12,142,558 | |||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 5,987 | |||
Equity | ||||
Stockholders’ equity: | ||||
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding | 1,407,495 | |||
Common stock, $0.01 par value per share | ||||
Class A, 949,000 shares authorized; 487,018 shares issued and outstanding | 4,871 | |||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | 7 | |||
Additional paid-in capital | 7,538,356 | |||
Distributions in excess of earnings | (3,307,886 | ) | ||
Accumulated other comprehensive income | 20,888 | |||
Total stockholders’ equity | 5,663,731 | |||
Noncontrolling interests in investment entities | 3,855,334 | |||
Noncontrolling interests in Operating Company | 456,384 | |||
Total equity | 9,975,449 | |||
Total liabilities, redeemable noncontrolling interests and equity | $ | 22,123,994 |
Colony Capital | Supplemental Financial Report | 19 |
IIIb. Financial Results - Noncontrolling Interests’ Share Balance Sheet |
($ in thousands, except per share data) (unaudited) | As of September 30, 2019 | |||
Assets | ||||
Cash and cash equivalents | $ | 123,988 | ||
Restricted cash | 56,965 | |||
Real estate, net | 2,385,067 | |||
Loans receivable, net | 700,377 | |||
Equity and debt investments | 606,469 | |||
Deferred leasing costs and intangible assets, net | 68,770 | |||
Assets held for sale | 3,472,738 | |||
Other assets | 91,275 | |||
Total assets | $ | 7,505,649 | ||
Liabilities | ||||
Debt, net | $ | 1,998,072 | ||
Accrued and other liabilities | 135,356 | |||
Intangible liabilities, net | 29,100 | |||
Liabilities related to assets held for sale | 1,481,800 | |||
Total liabilities | 3,644,328 | |||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 5,987 | |||
Equity | ||||
Stockholders’ equity: | ||||
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding | — | |||
Common stock, $0.01 par value per share | ||||
Class A, 949,000 shares authorized; 487,018 shares issued and outstanding | — | |||
Class B, 1,000 shares authorized; 734 shares issued and outstanding | — | |||
Additional paid-in capital | — | |||
Distributions in excess of earnings | — | |||
Accumulated other comprehensive income | — | |||
Total stockholders’ equity | — | |||
Noncontrolling interests in investment entities | 3,855,334 | |||
Noncontrolling interests in Operating Company | — | |||
Total equity | 3,855,334 | |||
Total liabilities, redeemable noncontrolling interests and equity | $ | 7,505,649 |
Colony Capital | Supplemental Financial Report | 20 |
IIIc. Financial Results - Consolidated Segment Operating Results |
Three Months Ended September 30, 2019 | ||||||||||||||||||||||||||||||||
($ in thousands) (unaudited) | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Investment Management | Amounts not allocated to segments | Total | ||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||||||
Property operating income | $ | 135,017 | $ | — | $ | 218,265 | $ | — | $ | 108,873 | $ | — | $ | — | $ | 462,155 | ||||||||||||||||
Interest income | 956 | — | — | — | 38,734 | 101 | 446 | 40,237 | ||||||||||||||||||||||||
Fee income | — | — | — | — | — | 111,854 | — | 111,854 | ||||||||||||||||||||||||
Other income | 118 | — | 113 | — | 3,530 | 32,248 | 2,240 | 38,249 | ||||||||||||||||||||||||
Total revenues | 136,091 | — | 218,378 | — | 151,137 | 144,203 | 2,686 | 652,495 | ||||||||||||||||||||||||
Expenses | ||||||||||||||||||||||||||||||||
Property operating expense | 66,042 | — | 141,235 | — | 67,074 | — | — | 274,351 | ||||||||||||||||||||||||
Interest expense | 46,029 | — | 40,641 | — | 27,428 | 1,585 | 14,351 | 130,034 | ||||||||||||||||||||||||
Investment and servicing expense | 1,009 | — | 1,728 | — | 8,211 | 259 | 1,889 | 13,096 | ||||||||||||||||||||||||
Transaction costs | — | — | — | — | — | 100 | — | 100 | ||||||||||||||||||||||||
Placement fees | — | — | — | — | — | 64 | — | 64 | ||||||||||||||||||||||||
Depreciation and amortization | 38,998 | — | 36,133 | — | 17,152 | 65,219 | 1,503 | 159,005 | ||||||||||||||||||||||||
Provision for loan loss | — | — | — | — | 17,233 | — | — | 17,233 | ||||||||||||||||||||||||
Impairment loss | 92,885 | — | 31,555 | — | 53,459 | 387,000 | — | 564,899 | ||||||||||||||||||||||||
Compensation expense | ||||||||||||||||||||||||||||||||
Cash and equity-based compensation | 1,753 | — | 1,643 | — | 3,330 | 58,337 | 21,980 | 87,043 | ||||||||||||||||||||||||
Carried interest and incentive compensation | — | — | — | — | — | 10,846 | — | 10,846 | ||||||||||||||||||||||||
Administrative expenses | 784 | — | 15 | — | 2,574 | 3,163 | 15,477 | 22,013 | ||||||||||||||||||||||||
Total expenses | 247,500 | — | 252,950 | — | 196,461 | 526,573 | 55,200 | 1,278,684 | ||||||||||||||||||||||||
Other income (loss) | ||||||||||||||||||||||||||||||||
Gain on sale of real estate assets | 833 | — | — | — | 7,391 | — | — | 8,224 | ||||||||||||||||||||||||
Other gain (loss), net | (2,544 | ) | — | (37 | ) | — | (1,709 | ) | 51,346 | (91,618 | ) | (44,562 | ) | |||||||||||||||||||
Equity method earnings | — | — | — | 7,979 | 35,587 | 3,211 | — | 46,777 | ||||||||||||||||||||||||
Equity method earnings—carried interest | — | — | — | — | — | (474 | ) | — | (474 | ) | ||||||||||||||||||||||
Income (loss) before income taxes | (113,120 | ) | — | (34,609 | ) | 7,979 | (4,055 | ) | (328,287 | ) | (144,132 | ) | (616,224 | ) | ||||||||||||||||||
Income tax benefit (expense) | 566 | — | 244 | — | (1,105 | ) | (9,384 | ) | (289 | ) | (9,968 | ) | ||||||||||||||||||||
Income (loss) from continuing operations | (112,554 | ) | — | (34,365 | ) | 7,979 | (5,160 | ) | (337,671 | ) | (144,421 | ) | (626,192 | ) | ||||||||||||||||||
Income (loss) from discontinued operations | — | 38,981 | — | — | — | 21,369 | — | 60,350 | ||||||||||||||||||||||||
Net income (loss) | (112,554 | ) | 38,981 | (34,365 | ) | 7,979 | (5,160 | ) | (316,302 | ) | (144,421 | ) | (565,842 | ) | ||||||||||||||||||
Net income (loss) attributable to noncontrolling interests: | ||||||||||||||||||||||||||||||||
Redeemable noncontrolling interests | — | — | — | — | 364 | — | — | 364 | ||||||||||||||||||||||||
Investment entities | (21,790 | ) | 27,728 | (3,194 | ) | — | 13,108 | (682 | ) | — | 15,170 | |||||||||||||||||||||
Operating Company | (8,001 | ) | 990 | (2,812 | ) | 702 | (1,640 | ) | (27,787 | ) | (15,012 | ) | (53,560 | ) | ||||||||||||||||||
Net income (loss) attributable to Colony Capital, Inc. | (82,763 | ) | 10,263 | (28,359 | ) | 7,277 | (16,992 | ) | (287,833 | ) | (129,409 | ) | (527,816 | ) | ||||||||||||||||||
Preferred stock dividends | — | — | — | — | — | — | 27,137 | 27,137 | ||||||||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (82,763 | ) | $ | 10,263 | $ | (28,359 | ) | $ | 7,277 | $ | (16,992 | ) | $ | (287,833 | ) | $ | (156,546 | ) | $ | (554,953 | ) |
Colony Capital | Supplemental Financial Report | 21 |
IIId. Financial Results - Noncontrolling Interests’ Share Segment Operating Results |
Three Months Ended September 30, 2019 | |||||||||||||||||||||||||||||||||
($ in thousands) (unaudited) | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Investment Management | Amounts not allocated to segments | Total | |||||||||||||||||||||||||
Revenues | — | ||||||||||||||||||||||||||||||||
Property operating income | $ | 37,999 | $ | — | $ | 14,174 | $ | — | $ | 54,276 | $ | — | $ | — | $ | 106,449 | |||||||||||||||||
Interest income | 290 | — | — | — | 24,893 | — | — | 25,183 | |||||||||||||||||||||||||
Fee income | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Other income | 35 | — | 4 | — | 1,968 | — | — | 2,007 | |||||||||||||||||||||||||
Total revenues | 38,324 | — | 14,178 | — | 81,137 | — | — | 133,639 | |||||||||||||||||||||||||
Expenses | |||||||||||||||||||||||||||||||||
Property operating expense | 18,229 | — | 8,905 | — | 31,994 | — | — | 59,128 | |||||||||||||||||||||||||
Interest expense | 13,108 | — | 2,576 | — | 13,014 | — | — | 28,698 | |||||||||||||||||||||||||
Investment and servicing expense | 287 | — | 95 | — | 3,681 | — | — | 4,063 | |||||||||||||||||||||||||
Transaction costs | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Placement fees | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Depreciation and amortization | 11,235 | — | 2,351 | — | 9,860 | — | — | 23,446 | |||||||||||||||||||||||||
Provision for loan loss | — | — | — | — | 4,648 | — | — | 4,648 | |||||||||||||||||||||||||
Impairment loss | 19,898 | — | 3,444 | — | 21,849 | — | — | 45,191 | |||||||||||||||||||||||||
Compensation expense | |||||||||||||||||||||||||||||||||
Cash and equity-based compensation | 32 | — | — | — | 1,364 | — | — | 1,396 | |||||||||||||||||||||||||
Carried interest and incentive compensation | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||
Administrative expenses | 218 | — | — | — | 1,391 | 1 | — | 1,610 | |||||||||||||||||||||||||
Total expenses | 63,007 | — | 17,371 | — | 87,801 | 1 | — | 168,180 | |||||||||||||||||||||||||
Other income (loss) | |||||||||||||||||||||||||||||||||
Gain on sale of real estate assets | 248 | — | — | — | 4,956 | — | — | 5,204 | |||||||||||||||||||||||||
Other gain (loss), net | (772 | ) | — | (1 | ) | — | 1,518 | — | — | 745 | |||||||||||||||||||||||
Equity method earnings (losses) | — | — | — | — | 14,837 | 81 | 14,918 | ||||||||||||||||||||||||||
Equity method earnings—carried interest | — | — | — | — | — | (351 | ) | — | (351 | ) | |||||||||||||||||||||||
Income (loss) before income taxes | (25,207 | ) | — | (3,194 | ) | — | 14,647 | (271 | ) | — | (14,025 | ) | |||||||||||||||||||||
Income tax benefit (expense) | 178 | — | — | — | (1,175 | ) | — | — | (997 | ) | |||||||||||||||||||||||
Net income (loss) | (25,029 | ) | — | (3,194 | ) | — | 13,472 | (271 | ) | — | (15,022 | ) | |||||||||||||||||||||
Income (loss) from discontinued operations | — | 27,728 | — | — | — | — | — | 27,728 | |||||||||||||||||||||||||
Non-pro rata allocation of income (loss) to NCI | 3,239 | — | — | — | — | (411 | ) | — | 2,828 | ||||||||||||||||||||||||
Net income (loss) attributable to noncontrolling interests | $ | (21,790 | ) | $ | 27,728 | $ | (3,194 | ) | $ | — | $ | 13,472 | $ | (682 | ) | $ | — | $ | 15,534 |
Colony Capital | Supplemental Financial Report | 22 |
IIIe. Financial Results - Segment Reconciliation of Net Income to FFO & Core FFO |
Three Months Ended September 30, 2019 | ||||||||||||||||||||||||||||||||||||||||
OP pro rata share by segment | Amounts attributable to noncontrolling interests | CLNY consolidated as reported | ||||||||||||||||||||||||||||||||||||||
($ in thousands) (Unaudited) | Healthcare | Industrial | Hospitality | CLNC | Other Equity and Debt | Investment Management | Amounts not allocated to segments | Total OP pro rata share | ||||||||||||||||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (82,763 | ) | $ | 10,263 | $ | (28,359 | ) | $ | 7,277 | $ | (16,992 | ) | $ | (287,833 | ) | $ | (156,546 | ) | $ | (554,953 | ) | $ | — | $ | (554,953 | ) | |||||||||||||
Net income (loss) attributable to noncontrolling common interests in Operating Company | (8,001 | ) | 990 | (2,812 | ) | 702 | (1,640 | ) | (27,787 | ) | (15,012 | ) | (53,560 | ) | — | (53,560 | ) | |||||||||||||||||||||||
Net income (loss) attributable to common interests in Operating Company and common stockholders | (90,764 | ) | 11,253 | (31,171 | ) | 7,979 | (18,632 | ) | (315,620 | ) | (171,558 | ) | (608,513 | ) | — | (608,513 | ) | |||||||||||||||||||||||
Adjustments for FFO: | ||||||||||||||||||||||||||||||||||||||||
Real estate depreciation and amortization | 28,758 | 4,212 | 33,782 | 9,298 | 8,226 | 1,722 | — | 85,998 | 30,617 | 116,615 | ||||||||||||||||||||||||||||||
Impairment of real estate | 72,987 | — | 28,111 | — | 31,610 | — | — | 132,708 | 45,192 | 177,900 | ||||||||||||||||||||||||||||||
Gain from sales of real estate | (585 | ) | (1,569 | ) | — | — | (2,463 | ) | — | — | (4,617 | ) | (8,311 | ) | (12,928 | ) | ||||||||||||||||||||||||
Less: Adjustments attributable to noncontrolling interests in investment entities | — | — | — | — | — | — | — | — | (67,498 | ) | (67,498 | ) | ||||||||||||||||||||||||||||
FFO | $ | 10,396 | $ | 13,896 | $ | 30,722 | $ | 17,277 | $ | 18,741 | $ | (313,898 | ) | $ | (171,558 | ) | $ | (394,424 | ) | $ | — | $ | (394,424 | ) | ||||||||||||||||
Additional adjustments for Core FFO: | ||||||||||||||||||||||||||||||||||||||||
(Gains) and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO(1) | — | — | — | — | (39,299 | ) | — | — | (39,299 | ) | (660 | ) | (39,959 | ) | ||||||||||||||||||||||||||
(Gains) and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment | — | — | — | — | — | 387,000 | — | 387,000 | — | 387,000 | ||||||||||||||||||||||||||||||
CLNC Core Earnings & NRE Cash Available for Distribution adjustments(2) | — | — | — | (2,804 | ) | 7,867 | — | — | 5,063 | — | 5,063 | |||||||||||||||||||||||||||||
Equity-based compensation expense | 607 | 696 | 606 | 1,058 | 684 | 3,815 | 4,124 | 11,590 | — | 11,590 | ||||||||||||||||||||||||||||||
Straight-line rent revenue and expense | 2,451 | (1,227 | ) | 280 | — | (901 | ) | 278 | (107 | ) | 774 | (1,240 | ) | (466 | ) | |||||||||||||||||||||||||
Amortization of acquired above- and below-market lease values, net | (1,562 | ) | (358 | ) | — | (261 | ) | (58 | ) | — | — | (2,239 | ) | (1,330 | ) | (3,569 | ) | |||||||||||||||||||||||
Amortization of deferred financing costs and debt premiums and discounts | 2,412 | 519 | 3,646 | 120 | 2,508 | 92 | 1,740 | 11,037 | 5,121 | 16,158 | ||||||||||||||||||||||||||||||
Unrealized fair value losses on interest rate and foreign currency hedges, and foreign currency remeasurements and realized gains and losses on interest rate hedging instruments existing at the time of the January 2017 merger with remaining terms greater than one year that served as economic hedges for any financing or refinancing of the Company's real estate verticals | 1,797 | — | — | 894 | (587 | ) | 8 | 91,487 | 93,599 | (277 | ) | 93,322 | ||||||||||||||||||||||||||||
Acquisition and merger-related transaction costs | — | — | — | — | — | 101 | — | 101 | — | 101 | ||||||||||||||||||||||||||||||
Restructuring and merger integration costs(3) | — | 1,021 | — | — | 10 | 13,297 | 4,222 | 18,550 | 42 | 18,592 | ||||||||||||||||||||||||||||||
Amortization and impairment of investment management intangibles | — | — | — | — | — | 65,158 | — | 65,158 | — | 65,158 | ||||||||||||||||||||||||||||||
Non-real estate depreciation and amortization | — | 30 | — | — | 3 | 45 | 1,503 | 1,581 | 7 | 1,588 | ||||||||||||||||||||||||||||||
Gain on consolidation of equity method investment | — | — | — | — | — | (51,400 | ) | — | (51,400 | ) | — | (51,400 | ) | |||||||||||||||||||||||||||
Tax effect of Core FFO adjustments, net | — | (234 | ) | — | — | (2 | ) | (4,286 | ) | (968 | ) | (5,490 | ) | (10 | ) | (5,500 | ) | |||||||||||||||||||||||
Less: Adjustments attributable to noncontrolling interests in investment entities | — | — | — | — | — | — | — | — | (1,653 | ) | (1,653 | ) | ||||||||||||||||||||||||||||
Core FFO | $ | 16,101 | $ | 14,343 | $ | 35,254 | $ | 16,284 | $ | (11,034 | ) | $ | 100,210 | $ | (69,557 | ) | $ | 101,601 | $ | — | $ | 101,601 |
(1) | Net of $47.4 million consolidated or $41.8 million CLNY OP share of depreciation, amortization and impairment charges previously adjusted to calculate FFO. |
(2) | Represents adjustments to align the Company’s Core FFO with CLNC’s definition of Core Earnings and NRE’s definition of Cash Available for Distribution (“CAD”) to reflect the Company’s percentage interest in the respective company’s earnings. |
(3) | Restructuring and merger integration costs primarily represent costs and charges incurred as a result of the corporate restructuring and reorganization plan announced in November 2018. Also included to a lesser degree are costs and charges related to the implementation of our strategic plan including the sale of the Industrial business. These integration and restructuring costs are not reflective of the Company’s core operating performance and the Company does not expect to incur these costs subsequent to the completion of the corporate restructuring and reorganization plan and the strategic plan. The majority of these costs consist of severance, employee costs of those separated or scheduled for separation, system integration and lease terminations. |
Colony Capital | Supplemental Financial Report | 23 |
IVa. Capitalization - Overview |
($ in thousands; except per share data; as of September 30, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | |||||||||
Debt (UPB) | |||||||||||
$750,000 Revolving credit facility | $ | 184,200 | $ | 184,200 | |||||||
Convertible/exchangeable senior notes | 616,105 | 616,105 | |||||||||
Corporate aircraft promissory note | 35,622 | 35,622 | |||||||||
Trust Preferred Securities ("TruPS") | 280,117 | 280,117 | |||||||||
Investment-level debt: | |||||||||||
Healthcare | 2,953,705 | 2,108,463 | |||||||||
Industrial | 2,149,494 | 762,316 | |||||||||
Hospitality | 2,659,615 | 2,488,740 | |||||||||
Other Equity and Debt | 2,119,352 | 1,104,610 | |||||||||
Total investment-level debt | 9,882,166 | 6,464,129 | |||||||||
Total debt | $ | 10,998,210 | $ | 7,580,173 | |||||||
Perpetual preferred equity, redemption value | |||||||||||
Total perpetual preferred equity | $ | 1,436,605 | |||||||||
Common equity as of November 5, 2019 | Price per share | Shares / Units | |||||||||
Class A and B common stock | $ | 5.48 | 487,749 | $ | 2,672,865 | ||||||
OP units(1) | 5.48 | 52,649 | 288,517 | ||||||||
Total market value of common equity | $ | 2,961,382 | |||||||||
Total market capitalization | $ | 11,978,160 |
(1) | Includes 21.5 million operating company units issued on July 25, 2019 for the acquisition of Digital Bridge Holdings. |
Colony Capital | Supplemental Financial Report | 24 |
IVb. Capitalization - Investment-Level Debt Overview |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | ||||||||||||||||
Non-recourse investment-level debt overview | ||||||||||||||||
Consolidated | CLNY OP share of consolidated amount | |||||||||||||||
Fixed / Floating | Unpaid principal balance | Unpaid principal balance | Wtd. avg. years remaining to maturity | Wtd. avg. interest rate(1) | ||||||||||||
Healthcare | Fixed | $ | 405,980 | $ | 285,039 | 5.4 | 4.5 | % | ||||||||
Healthcare | Floating | 2,547,725 | 1,823,424 | 3.9 | 5.6 | % | ||||||||||
Light Industrial(2) | Fixed | 1,588,045 | 532,917 | 8.8 | 3.8 | % | ||||||||||
Light Industrial(2) | Floating | 326,449 | 109,549 | 4.4 | 3.4 | % | ||||||||||
Bulk Industrial | Floating | 235,000 | 119,850 | 4.4 | 4.0 | % | ||||||||||
Hospitality | Fixed | 13,388 | 13,054 | 1.9 | 12.7 | % | ||||||||||
Hospitality | Floating | 2,646,227 | 2,475,686 | 3.3 | 5.1 | % | ||||||||||
Other Equity and Debt | ||||||||||||||||
Net lease real estate equity | Fixed | 104,821 | 104,198 | 3.7 | 5.0 | % | ||||||||||
Other real estate equity | Fixed | 55,831 | 15,979 | 3.4 | 2.6 | % | ||||||||||
Other real estate equity | Floating | 1,222,617 | 622,856 | 3.0 | 4.6 | % | ||||||||||
GP Co-investments | Floating | 734,864 | 361,334 | 2.2 | 3.7 | % | ||||||||||
GP Co-investments | Fixed | 1,219 | 243 | 3.8 | 2.4 | % | ||||||||||
Total investment-level debt | $ | 9,882,166 | $ | 6,464,129 | 4.0 | 5.0 | % | |||||||||
Fixed / Floating Summary | ||||||||||||||||
Fixed | $ | 2,169,284 | $ | 951,430 | ||||||||||||
Floating | 7,712,882 | 5,512,699 | ||||||||||||||
Total investment-level debt | $ | 9,882,166 | $ | 6,464,129 |
(1) | Based on 1-month LIBOR of 2.02% and 3-month LIBOR of 2.09% for floating rate debt. |
(2) | $300 million consolidated or $101 million CLNY OP share of Light Industrial floating rate (LIBOR plus 135bps) term debt is categorized as fixed rate debt to reflect interest rate swaps resulting in an effective fixed rate of 3.50%. |
Colony Capital | Supplemental Financial Report | 25 |
IVc. Capitalization - Revolving Credit Facility Overview |
($ in thousands, except as noted; as of September 30, 2019) | ||||
Revolving credit facility | ||||
Maximum principal amount | $ | 750,000 | ||
Amount outstanding | 184,200 | |||
Initial maturity | January 11, 2021 | |||
Fully-extended maturity | January 10, 2022 | |||
Interest rate | LIBOR + 2.25% | |||
Financial covenants as defined in the Credit Agreement: | Covenant level | |||
Consolidated Tangible Net Worth | Minimum $4,550 million | |||
Consolidated Fixed Charge Coverage Ratio(1) | Minimum 1.30 to 1.00 | |||
Interest Coverage Ratio(2) | Minimum 3.00 to 1.00 | |||
Consolidated Leverage Ratio | Maximum 0.65 to 1.00 | |||
Company status: As of September 30, 2019, CLNY is meeting all required covenant threshold levels |
(1) | In the event the Fixed Charge Coverage Ratio is between 1.50 and 1.30 to 1.00, the borrowing base formula will be discounted by 10%. |
(2) | Interest Coverage Ratio represents the ratio of the sum of (1) earnings from borrowing base assets and (2) certain investment management earnings divided by the greater of (a) actual interest expense on the revolving credit facility and (b) the average balance of the facility multiplied by 7.0% for the applicable quarter. |
Colony Capital | Supplemental Financial Report | 26 |
IVd. Capitalization - Corporate Securities Overview |
($ in thousands; except per share data; as of September 30, 2019, unless otherwise noted) | ||||||||||||||||||
Convertible/exchangeable debt | ||||||||||||||||||
Description | Outstanding principal | Final due date(1) | Interest rate | Conversion price (per share of common stock) | Conversion ratio | Conversion shares | ||||||||||||
5.0% Convertible senior notes | $ | 200,000 | April 15, 2023 | 5.00% fixed | $ | 15.76 | 63.4700 | 12,694 | ||||||||||
3.875% Convertible senior notes | 402,500 | January 15, 2021 | 3.875% fixed | 16.57 | 60.3431 | 24,288 | ||||||||||||
5.375% Exchangeable senior notes | 13,605 | June 15, 2033 | 5.375% fixed | 12.04 | 83.0837 | 1,130 | ||||||||||||
Total convertible debt | $ | 616,105 |
TruPS | ||||||||
Description | Outstanding principal | Final due date | Interest rate | |||||
Trust I | $ | 41,240 | March 30, 2035 | 3M L + 3.25% | ||||
Trust II | 25,780 | June 30, 2035 | 3M L + 3.25% | |||||
Trust III | 41,238 | January 30, 2036 | 3M L + 2.83% | |||||
Trust IV | 50,100 | June 30, 2036 | 3M L + 2.80% | |||||
Trust V | 30,100 | September 30, 2036 | 3M L + 2.70% | |||||
Trust VI | 25,100 | December 30, 2036 | 3M L + 2.90% | |||||
Trust VII | 31,459 | April 30, 2037 | 3M L + 2.50% | |||||
Trust VIII | 35,100 | July 30, 2037 | 3M L + 2.70% | |||||
Total TruPS | $ | 280,117 |
Perpetual preferred stock | |||||||||
Description | Liquidation preference | Shares outstanding (In thousands) | Callable period | ||||||
Series B 8.25% cumulative redeemable perpetual preferred stock | $ | 152,855 | 6,114 | Callable | |||||
Series E 8.75% cumulative redeemable perpetual preferred stock | 250,000 | 10,000 | Callable | ||||||
Series G 7.5% cumulative redeemable perpetual preferred stock | 86,250 | 3,450 | Callable | ||||||
Series H 7.125% cumulative redeemable perpetual preferred stock | 287,500 | 11,500 | On or after April 13, 2020 | ||||||
Series I 7.15% cumulative redeemable perpetual preferred stock | 345,000 | 13,800 | On or after June 5, 2022 | ||||||
Series J 7.125% cumulative redeemable perpetual preferred stock | 315,000 | 12,600 | On or after September 22, 2022 | ||||||
Total preferred stock | $ | 1,436,605 | 57,464 |
(1) | Callable at principal amount only if CLNY common stock has traded at least 130% of the conversion price for 20 of 30 consecutive trading days: on or after April 22, 2020, for the 5.0% convertible senior notes; on or after January 22, 2019, for the 3.875% convertible senior notes; and on or after on or after June 15, 2020, for the 5.375% exchangeable senior notes. |
Colony Capital | Supplemental Financial Report | 27 |
IVe. Capitalization - Debt Maturity and Amortization Schedules |
($ in thousands; as of September 30, 2019) | Payments due by period(1) | |||||||||||||||||||||||
Consolidated debt | Fixed / Floating | 2019 | 2020 | 2021 | 2022 | 2023 and after | Total | |||||||||||||||||
$750,000 Revolving credit facility | Floating | $ | — | $ | — | $ | — | $ | 184,200 | $ | — | $ | 184,200 | |||||||||||
Convertible/exchangeable senior notes | Fixed | — | — | 402,500 | — | 213,605 | 616,105 | |||||||||||||||||
Corporate aircraft promissory note | Fixed | 549 | 2,243 | 2,359 | 2,480 | 27,991 | 35,622 | |||||||||||||||||
TruPS | Floating | — | — | — | — | 280,117 | 280,117 | |||||||||||||||||
Investment-level debt: | ||||||||||||||||||||||||
Healthcare | Fixed | — | 6,809 | 8,083 | 9,068 | 382,020 | 405,980 | |||||||||||||||||
Healthcare(2) | Floating | 32,323 | 97,396 | 280,202 | 3,504 | 2,134,300 | 2,547,725 | |||||||||||||||||
Light Industrial(3) | Fixed | 213 | 5,825 | 2,690 | 6,735 | 1,572,582 | 1,588,045 | |||||||||||||||||
Light Industrial(3) | Floating | — | — | — | 1 | 326,448 | 326,449 | |||||||||||||||||
Bulk Industrial | Floating | — | — | — | — | 235,000 | 235,000 | |||||||||||||||||
Hospitality | Fixed | — | — | 13,388 | — | — | 13,388 | |||||||||||||||||
Hospitality | Floating | — | 132,250 | 207,177 | 1,630,000 | 676,800 | 2,646,227 | |||||||||||||||||
Other Equity and Debt | Fixed | 11,615 | 13,134 | 35,106 | 19,114 | 82,902 | 161,871 | |||||||||||||||||
Other Equity and Debt | Floating | 6,919 | 244,210 | 253,407 | 1,020,298 | 432,647 | 1,957,481 | |||||||||||||||||
Total consolidated debt | $ | 51,619 | $ | 501,867 | $ | 1,204,912 | $ | 2,875,400 | $ | 6,364,412 | $ | 10,998,210 | ||||||||||||
Pro rata debt | Fixed / Floating | 2019 | 2020 | 2021 | 2022 | 2023 and after | Total | |||||||||||||||||
$750,000 Revolving credit facility | Floating | $ | — | $ | — | $ | — | $ | 184,200 | $ | — | $ | 184,200 | |||||||||||
Convertible/exchangeable senior notes | Fixed | — | — | 402,500 | — | 213,605 | 616,105 | |||||||||||||||||
Corporate aircraft promissory note | Fixed | 549 | 2,243 | 2,359 | 2,480 | 27,991 | 35,622 | |||||||||||||||||
TruPS | Floating | — | — | — | — | 280,117 | 280,117 | |||||||||||||||||
Investment-level debt: | ||||||||||||||||||||||||
Healthcare | Fixed | — | 4,781 | 5,675 | 6,366 | 268,217 | 285,039 | |||||||||||||||||
Healthcare(2) | Floating | 26,239 | 74,020 | 224,827 | 2,451 | 1,495,887 | 1,823,424 | |||||||||||||||||
Light Industrial(3) | Fixed | 72 | 1,955 | 903 | 2,260 | 527,727 | 532,917 | |||||||||||||||||
Light Industrial(3) | Floating | — | — | — | — | 109,549 | 109,549 | |||||||||||||||||
Bulk Industrial | Floating | — | — | — | — | 119,850 | 119,850 | |||||||||||||||||
Hospitality | Fixed | — | — | 13,054 | — | — | 13,054 | |||||||||||||||||
Hospitality | Floating | — | 132,250 | 201,998 | 1,464,639 | 676,799 | 2,475,686 | |||||||||||||||||
Other Equity and Debt | Fixed | 3,538 | 4,808 | 26,736 | 6,610 | 78,728 | 120,420 | |||||||||||||||||
Other Equity and Debt | Floating | 2,306 | 82,965 | 228,038 | 523,108 | 147,773 | 984,190 | |||||||||||||||||
Total pro rata debt | $ | 32,704 | $ | 303,022 | $ | 1,106,090 | $ | 2,192,114 | $ | 3,946,243 | $ | 7,580,173 |
(1) | Based on initial maturity dates or extended maturity dates to the extent criteria are met and the extension option is at the borrower’s discretion. |
(2) | Proforma for refinancing of a £212 million healthcare loan with a fully extended five-year term subsequent to the third quarter 2019. |
(3) | $300 million consolidated or $101 million CLNY OP share of Light Industrial floating rate (LIBOR plus 135bps) term debt is categorized as fixed rate debt to reflect interest rate swaps resulting in an effective fixed rate of 3.50%. |
Colony Capital | Supplemental Financial Report | 28 |
Va. Healthcare Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount(1) | ||||||
Net operating income | ||||||||
Net operating income: | ||||||||
Senior Housing - Operating | $ | 15,612 | $ | 11,085 | ||||
Medical Office Buildings | 12,923 | 9,149 | ||||||
Triple-Net Lease: | ||||||||
Senior Housing(2) | 14,103 | 10,013 | ||||||
Skilled Nursing Facilities | 25,477 | 18,089 | ||||||
Hospitals | 3,169 | 2,250 | ||||||
Total net operating income | $ | 71,284 | $ | 50,586 |
Portfolio overview | Total number of properties | Capacity | % Occupied(3) | TTM Lease Coverage(4) | WA Remaining Lease Term | ||||||||
Senior Housing - Operating | 83 | 6,388 units | 85.3 | % | N/A | N/A | |||||||
Medical Office Buildings | 106 | 3.8 million sq. ft. | 82.2 | % | N/A | 4.6 | |||||||
Triple-Net Lease: | |||||||||||||
Senior Housing | 81 | 4,231 units | 80.5 | % | 1.2x | 11.0 | |||||||
Skilled Nursing Facilities | 89 | 10,601 beds | 82.5 | % | 1.2x | 5.7 | |||||||
Hospitals | 12 | 872 beds | 58.3 | % | 2.7x | 9.4 | |||||||
Total | 371 |
Same store financial/operating results related to the segment | ||||||||||||||||||||||
% Occupied(3) | TTM Lease Coverage(4) | NOI(5) | ||||||||||||||||||||
Q3 2019 | Q2 2019 | 6/30/2019 | 3/31/2019 | Q3 2019 | Q2 2019 | % Change | ||||||||||||||||
Senior Housing - Operating | 85.3 | % | 84.8 | % | N/A | N/A | $ | 15,611 | $ | 16,469 | (5.2 | )% | ||||||||||
Medical Office Buildings | 82.2 | % | 82.1 | % | N/A | N/A | 12,923 | 13,481 | (4.1 | )% | ||||||||||||
Triple-Net Lease: | ||||||||||||||||||||||
Senior Housing | 80.5 | % | 80.9 | % | 1.2x | 1.3x | 14,097 | 15,284 | (7.8 | )% | ||||||||||||
Skilled Nursing Facilities | 82.5 | % | 83.3 | % | 1.2x | 1.2x | 23,398 | 24,219 | (3.4 | )% | (5) | |||||||||||
Hospitals | 58.3 | % | 63.4 | % | 2.7x | 2.4x | 3,169 | 4,984 | (36.4 | )% | (5) | |||||||||||
Total | $ | 69,198 | $ | 74,437 | (7.0 | )% |
(1) | CLNY OP Share represents Consolidated NOI multiplied by CLNY OP's interest of 71% as of September 30, 2019. |
(2) | NOI includes $1.0 million consolidated or $0.7 million CLNY OP share of interest earned related to $54 million consolidated or $38 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended September 30, 2019. For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
(3) | Occupancy % for Senior Housing - Operating represents average of the presented quarter, MOB’s is as of last day in the quarter and for Triple-Net Lease represents average of the prior quarter. Occupancy represents real estate property operator’s patient occupancy for all types except MOB. |
(4) | Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR. |
(5) | Third quarter 2019 same store net operating income included a $1.6 million consolidated, or $1.2 million CLNY OP share, one-time write-off of a certain tenant rent receivable in the Hospitals portfolio and second quarter 2019 same store net operating income included a $0.9 million consolidated, or $0.7 million CLNY OP share, one-time recovery of a certain tenant rent receivable in the Skilled Nursing Facilities portfolio. Excluding these one-time items from same store NOI, the healthcare same store portfolio sequential quarter to quarter comparable net operating income would have decreased (3.7)%. |
Colony Capital | Supplemental Financial Report | 29 |
Vb. Healthcare Real Estate - Portfolio Overview |
(As of or for the three months ended September 30, 2019, unless otherwise noted) | |||||||||||||||
Triple-Net Lease Coverage(1) | % of Triple-Net Lease TTM NOI as of June 30, 2019 | ||||||||||||||
June 30, 2019 TTM Lease Coverage | # of Leases | Senior Housing | Skilled Nursing Facilities & Hospitals | % Triple-Net Lease NOI | WA Remaining Lease Term | ||||||||||
Less than 0.99x | 6 | 6 | % | 14 | % | 20 | % | 6 yrs | |||||||
1.00x - 1.09x | 1 | — | % | 11 | % | 11 | % | 7 yrs | |||||||
1.10x - 1.19x | 1 | 4 | % | — | % | 4 | % | 8 yrs | |||||||
1.20x - 1.29x | 1 | — | % | 12 | % | 12 | % | 9 yrs | |||||||
1.30x - 1.39x | 3 | 22 | % | 9 | % | 31 | % | 11 yrs | |||||||
1.40x - 1.49x | — | — | % | — | % | — | % | — | |||||||
1.50x and greater | 4 | 2 | % | 20 | % | 22 | % | 4 yrs | |||||||
Total / W.A. | 16 | 34 | % | 66 | % | 100 | % | 8 yrs |
Revenue Mix(2) | June 30, 2019 TTM | ||||||||
Private Pay | Medicare | Medicaid | |||||||
Senior Housing - Operating | 86 | % | 4 | % | 10 | % | |||
Medical Office Buildings | 100 | % | — | % | — | % | |||
Triple-Net Lease: | |||||||||
Senior Housing | 63 | % | — | % | 37 | % | |||
Skilled Nursing Facilities | 27 | % | 20 | % | 53 | % | |||
Hospitals | 14 | % | 42 | % | 44 | % | |||
W.A. | 61 | % | 9 | % | 30 | % |
(1) | Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR. Represents leases with EBITDAR coverage in each listed range. Excludes interest income associated with triple-net lease senior housing and hospital types. Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator. |
(2) | Revenue mix represents percentage of revenues derived from private, Medicare and Medicaid payor sources. The payor source percentages for the hospital category excludes two operating partners, whom do not track or report payor source data and totals approximately one-third of NOI in the hospital category. Overall percentages are weighted by NOI exposure in each category. |
Colony Capital | Supplemental Financial Report | 30 |
Vb. Healthcare Real Estate - Portfolio Overview (cont’d) |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | |||||||
Top 10 Geographic Locations by NOI | |||||||
Number of properties | NOI | ||||||
United Kingdom | 45 | $ | 9,596 | ||||
Indiana | 55 | 7,186 | |||||
Illinois | 35 | 6,764 | |||||
Florida | 25 | 6,450 | |||||
Pennsylvania | 8 | 5,022 | |||||
Texas | 29 | 4,546 | |||||
Oregon | 31 | 4,413 | |||||
Georgia | 21 | 4,188 | |||||
Ohio | 14 | 4,158 | |||||
California | 12 | 3,689 | |||||
Total | 275 | $ | 56,012 |
Top 10 Operators/Tenants by NOI | ||||||||||||||||
Property Type/Primary Segment | Number of properties | NOI | % Occupied | TTM Lease Coverage | WA Remaining Lease Term | |||||||||||
Senior Lifestyle | Sr. Housing / RIDEA | 60 | $ | 12,589 | 87.0 | % | N/A | N/A | ||||||||
Caring Homes (U.K.)(1) | Sr. Housing / NNN | 45 | 9,596 | 86.0 | % | 1.4x | 14 yrs | |||||||||
Sentosa | SNF / NNN | 8 | 5,022 | 83.0 | % | 1.2x | 9 yrs | |||||||||
Wellington Healthcare | SNF / NNN | 10 | 4,236 | 90.0 | % | 1.0x | 7 yrs | |||||||||
Millers | SNF / NNN | 28 | 3,990 | 70.0 | % | 1.8x | N/A | |||||||||
Frontier | Sr. Housing / RIDEA / NNN | 20 | 3,432 | 81.0 | % | N/A | N/A | |||||||||
Opis | SNF / NNN | 11 | 2,880 | 92.0 | % | 1.4x | 4 yrs | |||||||||
Consulate | SNF / NNN | 10 | 2,377 | 90.0 | % | 1.1x | 8 yrs | |||||||||
Avanti Hospital Systems | Hospital | 3 | 2,361 | 55.0 | % | 4.5x | 8 yrs | |||||||||
Carillon | Sr. Housing / NNN | 6 | 2,085 | 50.0 | % | 0.9x | 8 yrs | |||||||||
Total | 201 | $ | 48,568 |
(1) | Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator. |
Colony Capital | Supplemental Financial Report | 31 |
VIa. Industrial Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | Consolidated amount(1) | CLNY OP share of consolidated amount(1) | ||||||
Net operating income | ||||||||
Light Industrial | $ | 63,326 | $ | 21,251 | ||||
Bulk Industrial | 3,465 | 1,767 | ||||||
Total Industrial | $ | 66,791 | $ | 23,018 |
Portfolio overview | Light | Bulk | Total | ||||||
Total number of buildings | 450 | 6 | 456 | ||||||
Rentable square feet (thousands) | 57,403 | 4,183 | 61,586 | ||||||
% leased at end of period | 90.9 | % | 67.4 | % | |||||
Average remaining lease term | 3.9 | 11.5 |
Light industrial same store financial/operating results | Q3 2019 | Q2 2019 | % Change | ||||||||
Same store number of buildings | 311 | 311 | — | ||||||||
% leased at end of period | 95.0 | % | 94.5 | % | 0.5 | % | |||||
NOI | $ | 43,110 | $ | 42,217 | 2.1 | % |
(1) | CLNY OP Share represents Consolidated NOI multiplied by CLNY OP's light industrial portfolio interest of 34% and bulk industrial portfolio interest of 51% as of September 30, 2019. For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation. |
Colony Capital | Supplemental Financial Report | 32 |
VIb. Industrial Real Estate - Portfolio Overview |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | |||||||||||||
Top 10 Geographic Locations by NOI - Light Industrial Portfolio | Number of buildings | Rentable square feet (thousands) | NOI | % leased at end of period | |||||||||
Atlanta | 54 | 6,979 | $ | 7,722 | 98.5 | % | |||||||
Dallas | 63 | 6,982 | 7,611 | 96.9 | % | ||||||||
Chicago | 37 | 5,128 | 4,536 | 88.9 | % | ||||||||
Northern New Jersey | 41 | 2,261 | 4,404 | 97.9 | % | ||||||||
Orlando | 23 | 3,575 | 3,760 | 81.6 | % | ||||||||
Minneapolis | 18 | 2,814 | 3,545 | 96.2 | % | ||||||||
Phoenix | 24 | 2,988 | 3,828 | 98.6 | % | ||||||||
Baltimore | 23 | 2,956 | 3,428 | 95.1 | % | ||||||||
Philadelphia | 24 | 3,109 | 3,194 | 89.3 | % | ||||||||
Jacksonville | 13 | 2,305 | 1,974 | 92.0 | % | ||||||||
Total / W.A. | 320 | 39,097 | $ | 44,002 | 93.9 | % |
Top 10 Tenant Base by Industry - Light Industrial Portfolio | ||||||
Industry | Total leased square feet (thousands) | % of total | ||||
Warehousing & Transportation | 22,689 | 43.6 | % | |||
Manufacturing | 9,009 | 17.3 | % | |||
Professional, Scientific & Technical Services | 4,864 | 9.3 | % | |||
Wholesale Trade | 4,776 | 9.2 | % | |||
Health & Science | 3,563 | 6.8 | % | |||
Media & Information | 2,612 | 5.0 | % | |||
Construction & Contractors | 2,192 | 4.2 | % | |||
Retail Trade | 1,610 | 3.1 | % | |||
Entertainment & Recreation | 686 | 1.3 | % | |||
Public Administration & Government | 84 | 0.2 | % | |||
Total | 52,085 | 100.0 | % |
Colony Capital | Supplemental Financial Report | 33 |
VIIa. Hospitality Real Estate - Summary Metrics and Operating Results |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | CLNY OP share of consolidated amount(1) | |||||||
NOI before FF&E Reserve | Consolidated amount | |||||||
NOI before FF&E Reserve: | ||||||||
Select Service | $ | 40,143 | $ | 37,694 | ||||
Extended Stay | 34,195 | 32,109 | ||||||
Full Service | 3,050 | 2,864 | ||||||
Total NOI before FF&E Reserve(2) | $ | 77,388 | $ | 72,667 |
Portfolio overview by type | ||||||||||||||||||||||||
Number of hotels | Number of rooms | Avg. qtr. % occupancy | Avg. daily rate (ADR) | RevPAR | Q3 2019 NOI before FF&E Reserve | NOI before FF&E Reserve margin | ||||||||||||||||||
Select service | 88 | 11,886 | 76.2 | % | $ | 124 | $ | 95 | $ | 40,143 | 34.1 | % | ||||||||||||
Extended stay | 66 | 7,936 | 83.5 | % | 137 | 114 | 34,195 | 39.6 | % | |||||||||||||||
Full service | 4 | 966 | 74.1 | % | 159 | 118 | 3,050 | 21.2 | % | |||||||||||||||
Total / W.A. | 158 | 20,788 | 78.8 | % | $ | 131 | $ | 103 | $ | 77,388 | 35.4 | % |
Same store financial/operating results related to the segment by brand | ||||||||||||||||||||||||||||||||||
Avg. qtr. % occupancy | Avg. daily rate (ADR) | RevPAR | NOI before FF&E Reserve | |||||||||||||||||||||||||||||||
Brand | Q3 2019 | Q3 2018 | Q3 2019 | Q3 2018 | Q3 2019 | Q3 2018 | Q3 2019 | Q3 2018 | % Change | |||||||||||||||||||||||||
Marriott | 77.4 | % | 77.8 | % | $ | 130 | $ | 130 | $ | 101 | $ | 101 | $ | 57,006 | $ | 57,238 | (0.4 | )% | ||||||||||||||||
Hilton | 83.7 | % | 84.8 | % | 133 | 132 | 111 | 112 | 15,380 | 13,587 | 13.2 | % | (3) | |||||||||||||||||||||
Other | 86.6 | % | 85.4 | % | 139 | 139 | 120 | 118 | 4,835 | 4,614 | 4.8 | % | ||||||||||||||||||||||
Total / W.A. | 79.0 | % | 79.4 | % | $ | 131 | $ | 131 | $ | 104 | $ | 104 | $ | 77,221 | $ | 75,439 | 2.4 | % |
(1) | CLNY OP Share represents Consolidated NOI before FF&E Reserve multiplied by CLNY OP's interest of 94% as of September 30, 2019. |
(2) | Q3 2019 FF&E reserve was $9.4 million consolidated or $8.8 million CLNY OP share. For a reconciliation of net income/(loss) attributable to common stockholders to NOI please refer to the appendix to this presentation. |
(3) | Third quarter 2019 NOI included a one-time $1.6 million benefit from the reversal of property taxes that were accrued prior to 2018. |
Colony Capital | Supplemental Financial Report | 34 |
VIIb. Hospitality Real Estate - Portfolio Overview |
($ in thousands; as of September 30, 2019, unless otherwise noted) | |||||||||||||||||||
Top 10 Geographic Locations by NOI before FF&E Reserve | Number of hotels | Number of rooms | Number of rooms-select service | Number of rooms-extended stay | Number of rooms-full service | NOI before FF&E Reserve | |||||||||||||
California | 18 | 2,254 | 1,243 | 1,011 | — | $ | 13,011 | ||||||||||||
Texas | 26 | 2,939 | 1,661 | 1,278 | — | 7,335 | |||||||||||||
New Jersey | 12 | 1,884 | 718 | 942 | 224 | 6,527 | |||||||||||||
New York | 8 | 1,010 | 710 | 300 | — | 5,977 | |||||||||||||
Washington | 5 | 664 | 160 | 504 | — | 4,792 | |||||||||||||
Florida | 12 | 2,065 | 1,187 | 291 | 587 | 4,420 | |||||||||||||
New Hampshire | 6 | 662 | 339 | 323 | — | 3,747 | |||||||||||||
North Carolina | 7 | 981 | 831 | 150 | — | 3,505 | |||||||||||||
Virginia | 9 | 1,183 | 920 | 263 | — | 3,444 | |||||||||||||
Michigan | 6 | 809 | 601 | 208 | — | 3,300 | |||||||||||||
Total / W.A. | 109 | 14,451 | 8,370 | 5,270 | 811 | $ | 56,058 |
Colony Capital | Supplemental Financial Report | 35 |
VIIIa. CLNC |
($ in thousands, except as noted and per share data; as of September 30, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
Colony Credit Real Estate, Inc. (NYSE: CLNC) | ||||||||
CLNY OP interest in CLNC as of November 5, 2019 | 36.4 | % | 36.4 | % | ||||
CLNC shares beneficially owned by OP and common stockholders | 48.0 million | 48.0 million | ||||||
CLNC share price as of November 5, 2019 | $ | 14.20 | $ | 14.20 | ||||
Total market value of CLNC shares | $ | 680,705 | $ | 680,705 | ||||
Net carrying value - CLNC | $ | 731,306 | $ | 731,306 | ||||
Colony Capital | Supplemental Financial Report | 36 |
IX. Other Equity and Debt Summary |
($ in thousands; as of September 30, 2019) | Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Assets | Equity | Assets | Equity | ||||||||||||
Strategic GP co-investments(1) | $ | 2,766,121 | $ | 1,909,472 | $ | 1,144,949 | $ | 662,808 | |||||||
Non-Strategic(1) | |||||||||||||||
Other real estate equity | 2,207,140 | 928,693 | 1,184,593 | 545,757 | |||||||||||
Net lease real estate equity | 185,148 | 80,326 | 184,126 | 79,928 | |||||||||||
Real estate debt | 351,074 | 351,074 | 243,716 | 243,716 | |||||||||||
CRE securities and real estate PE fund investments | 65,387 | 65,387 | 65,387 | 65,387 | |||||||||||
Non-Strategic Subtotal | 2,808,749 | 1,425,480 | 1,677,822 | 934,788 | |||||||||||
Other Equity and Debt Total | $ | 5,574,870 | $ | 3,334,952 | $ | 2,822,771 | $ | 1,597,596 |
(1) | For consolidated real estate equity assets, amounts include all components related to real estate assets, including tangible real estate and lease-related intangibles, and excludes accumulated depreciation, and for all other assets, amounts represent carrying value of investments. |
Colony Capital | Supplemental Financial Report | 37 |
IXa. Other Equity and Debt - Strategic Investments |
($ in thousands, except as noted and per share data; as of September 30, 2019, unless otherwise noted) | Consolidated amount | CLNY OP share of consolidated amount | ||||||
CLNY's GP Co-investments in CDCF IV and CDCF V Investments | ||||||||
Assets - carrying value(1) | $ | 1,985,428 | $ | 374,424 | ||||
Debt - UPB | 494,628 | 120,120 | ||||||
Net carrying value | $ | 1,490,800 | $ | 254,304 | ||||
NBV by Geography: | ||||||||
U.S. | 28.3 | % | 20.7 | % | ||||
Europe | 71.7 | % | 79.3 | % | ||||
Total | 100.0 | % | 100.0 | % | ||||
Other GP Co-investments (2) | ||||||||
Assets - carrying value(3)(4) | $ | 780,693 | $ | 770,525 | ||||
Debt - UPB(4) | 362,021 | 362,021 | ||||||
Net carrying value | $ | 418,672 | $ | 408,504 |
(1) | $741 million consolidated or $116 million CLNY OP share of assets are classified as Loans Receivable on the Company's balance sheet. |
(2) | Other GP co-investments represents: i) seed investments in certain registered investment companies sponsored by the Company, ii) investments in the general partnership of third party real estate operators primarily to seed investment commitments with their limited partners for which the Company will receive its share of earnings and incentive fees, or iii) general partnership capital in a fund or investment. |
(3) | $360 million consolidated and CLNY OP share of assets are classified as Loans Receivable on the Company's balance sheet. |
(4) | Debt includes $121 million of derivative liability with a corresponding derivative asset in Other GP Co-investments Assets above. |
Colony Capital | Supplemental Financial Report | 38 |
IXb. Other Equity and Debt - Net Lease and Other Real Estate Equity |
($ in thousands; as of September 30, 2019, unless otherwise noted) | ||||||||||||||||||||
Net Lease Real Estate Equity | Number of buildings | Rentable square feet (thousands) | Consolidated amount | CLNY OP share of consolidated amount | % leased at end of period | Weighted average remaining lease term | ||||||||||||||
NOI | NOI | |||||||||||||||||||
U.S. office | 3 | 674 | $ | 1,092 | $ | 1,088 | 85.7 | % | 5.1 | |||||||||||
Total / W.A. | 3 | 674 | $ | 1,092 | $ | 1,088 | 85.7 | % | 5.1 |
Other Real Estate Equity | Number of buildings | Rentable square feet (thousands) | Consolidated amount | CLNY OP share of consolidated amount | % leased at end of period | Weighted average remaining lease term | ||||||||||||||
Undepreciated carrying value | Undepreciated carrying value | |||||||||||||||||||
U.S.: | ||||||||||||||||||||
Office | 3 | 366 | $ | 64,453 | $ | 61,362 | 67.1 | % | 4.6 | |||||||||||
Hotel(1) | 89 | N/A | 1,213,864 | 669,101 | 73.0 | % | N/A | |||||||||||||
Europe: | ||||||||||||||||||||
Office | 15 | 533 | 72,235 | 36,117 | 76.1 | % | 11.8 | |||||||||||||
Mixed / Retail | 115 | 3,381 | 539,123 | 179,982 | 51.4 | % | 4.5 | |||||||||||||
Total / W.A. | 222 | 4,280 | $ | 1,889,675 | $ | 946,562 | 55.8 | % | 5.4 | |||||||||||
Unconsolidated joint ventures (Other RE Equity) | ||||||||||||||||||||
Preferred equity: | ||||||||||||||||||||
Multifamily | $ | 128,894 | $ | 128,894 | ||||||||||||||||
Equity & Other: | ||||||||||||||||||||
Albertsons | 89,129 | 44,565 | ||||||||||||||||||
Residential Land | 70,700 | 35,830 | ||||||||||||||||||
Other | 28,742 | 28,742 | ||||||||||||||||||
Total | $ | 317,465 | $ | 238,031 | ||||||||||||||||
(1) | Includes $40 million consolidated or $22 million CLNY OP share of restricted cash. |
Colony Capital | Supplemental Financial Report | 39 |
IXc. Other Equity and Debt - Real Estate Debt |
($ in thousands, except as noted; as of September 30, 2019, unless otherwise noted) | ||||||||
Portfolio Overview(1) | ||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||
Non-PCI loans(2) | ||||||||
Carrying value - consolidated | $ | 290,547 | $ | 207,626 | ||||
Carrying value - equity method investments | 14,156 | 9,087 | ||||||
. | ||||||||
PCI loans(2) | ||||||||
Carrying value - consolidated | — | — | ||||||
Carrying value - equity method investments | 974 | 974 | ||||||
Other | ||||||||
Carrying value - real estate assets (REO) | 45,397 | 26,029 | ||||||
Total Portfolio | ||||||||
Carrying value - consolidated | 290,547 | 207,626 | ||||||
Carrying value - equity method investments | 15,130 | 10,061 | ||||||
Carrying value - real estate assets (REO) | 45,397 | 26,029 | ||||||
Non-recourse investment-level financing (UPB) | — | — |
(1) | Excludes $54 million consolidated or $38 million CLNY OP share carrying value of healthcare real estate development loans. |
(2) | Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 40 |
IXc. Other Equity and Debt - Real Estate Debt (cont’d) |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | ||||||||||||||
Non-strategic real estate debt by loan type(1) | ||||||||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Net carrying amount | Net carrying amount | Weighted average yield | Weighted average maturity in years | |||||||||||
Non-PCI loans(2) | ||||||||||||||
Fixed rate | ||||||||||||||
First mortgage loans | $ | 33,988 | $ | 16,994 | — | % | 0.7 | |||||||
Second mortgage loans / B-notes | 174,878 | 98,240 | 9.4 | % | 1.9 | |||||||||
Mezzanine loans | 59,819 | 57,256 | — | % | 1.7 | |||||||||
Corporate | 27,618 | 27,618 | 8.1 | % | 7.3 | |||||||||
Total fixed rate non-PCI loans | 296,303 | 200,108 | 5.8 | % | 2.5 | |||||||||
Variable rate | ||||||||||||||
First mortgage loans | 42,394 | 42,394 | 8.9 | % | 1.2 | |||||||||
Total variable rate non-PCI loans | 42,394 | 42,394 | 8.9 | % | 1.2 | |||||||||
Total non-PCI loans | 338,697 | 242,502 | ||||||||||||
Allowance for loan losses | (48,150 | ) | (34,876 | ) | ||||||||||
Total non-PCI loans, net of allowance for loan losses | 290,547 | 207,626 | ||||||||||||
PCI loans(2) | ||||||||||||||
Mezzanine loans | 3,671 | 3,671 | ||||||||||||
Total PCI loans | 3,671 | 3,671 | ||||||||||||
Allowance for loan losses | (3,671 | ) | (3,671 | ) | ||||||||||
Total PCI loans, net of allowance for loan losses | — | — | ||||||||||||
Total loans receivable, net of allowance for loan losses | $ | 290,547 | $ | 207,626 |
(1) | Excludes $54 million consolidated or $38 million CLNY OP share carrying value of healthcare real estate development loans. |
(2) | Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 41 |
IXc. Other Equity and Debt - Real Estate Debt (cont’d) |
($ in thousands; as of or for the three months ended September 30, 2019, unless otherwise noted) | ||||||||||||||
Non-strategic real estate debt by collateral type(1) | ||||||||||||||
Consolidated amount | CLNY OP share of consolidated amount | |||||||||||||
Net carrying amount | Net carrying amount | Weighted average yield | Weighted average maturity in years | |||||||||||
Non-PCI Loans(2) | ||||||||||||||
Retail | $ | 102,213 | $ | 99,650 | 3.8 | % | 1.5 | |||||||
Office | 137,112 | 68,556 | 13.5 | % | 2.3 | |||||||||
Land | 23,604 | 11,802 | — | % | 0.7 | |||||||||
Corporate | 27,618 | 27,618 | 8.1 | % | 7.3 | |||||||||
Total non-PCI loans, net of allowance for loan losses | 290,547 | 207,626 | 7.4 | % | 2.5 | |||||||||
Total loans receivable, net of allowance for loan losses | $ | 290,547 | $ | 207,626 |
(1) | Excludes $54 million consolidated or $38 million CLNY OP share carrying value of healthcare real estate development loans. |
(2) | Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation. |
Colony Capital | Supplemental Financial Report | 42 |
IXd. Other Equity and Debt - CRE Securities and Real Estate PE Fund Interests |
($ in thousands; as of September 30, 2019) | |||||
Portfolio Overview | Carrying Value | ||||
Deconsolidated CDO bonds | $ | 59,953 | |||
Real estate PE fund interests | 5,434 | ||||
Colony Capital | Supplemental Financial Report | 43 |
Xa. Investment Management - Summary Metrics |
($ in thousands, except as noted; as of September 30, 2019) | ||||
Fee Revenue | CLNY OP Share | |||
Digital Bridge Holdings(1) | $ | 13,434 | ||
Institutional funds | 13,602 | |||
Colony Credit Real Estate (NYSE:CLNC) | 11,269 | |||
NorthStar Realty Europe (NYSE:NRE)(2) | 68,364 | |||
Retail companies | 5,185 | |||
Non-wholly owned REIM platforms (equity method earnings) | 4,539 | |||
Total reported fee revenue and REIM platform equity method earnings | $ | 116,393 | ||
Operating Results | ||||
Revenues | ||||
Total fee revenue and REIM earnings of investments in unconsolidated ventures | $ | 116,393 | ||
Interest Income and Other Income(3) | 32,349 | |||
Expenses | ||||
Interest expense | 1,585 | |||
Investment and servicing expense | 259 | |||
Transaction costs | 100 | |||
Placement fees | 64 | |||
Depreciation and amortization(4) | 65,219 | |||
(Recovery of) impairment loss(5) | 387,000 | |||
Compensation expense | ||||
Cash and equity-based compensation(3) | 58,337 | |||
Carried interest and incentive compensation | 10,846 | |||
Administrative expenses | 3,162 | |||
Total expenses | 526,572 | |||
Other gain (loss), net(6) | 51,346 | |||
Equity method earnings | (1,409 | ) | ||
Equity method earnings—carried interest | (123 | ) | ||
Income tax benefit (expense) | (9,384 | ) | ||
Income (loss) from discontinued operations(7) | 21,369 | |||
Non-pro rata allocation of income (loss) to NCI | 411 | |||
Net income attributable to common interests in OP and common stockholders | (315,620 | ) | ||
Real estate depreciation and amortization | 1,722 | |||
(Gains) and losses from sales of businesses and impairment write-downs associated with the Investment Management segment(5) | 387,000 | |||
Equity-based compensation expense | 3,815 | |||
Straight-line rent revenue and expense | 278 | |||
Amortization of deferred financing costs and debt premiums and discounts | 92 | |||
Unrealized fair value losses on interest rate and foreign currency hedges, and foreign currency remeasurements | 8 | |||
Acquisition and merger-related transaction costs | 101 | |||
Restructuring and merger integration costs(3) | 13,297 | |||
Amortization and impairment of investment management intangibles(4) | 65,158 | |||
Non-real estate depreciation and amortization | 45 | |||
Gain on consolidation of equity method investment(6) | (51,400 | ) | ||
Tax effect of Core FFO adjustments, net | (4,286 | ) | ||
Core FFO | $ | 100,210 |
Colony Capital | Supplemental Financial Report | 44 |
Xa. Investment Management - Summary Metrics |
(1) | The Company acquired Digital Bridge Holdings on July 25, 2019 and recognized fee revenue for the period between July 26, 2019 through September 30, 2019. |
(2) | Includes $3.8 million of quarterly base management fees plus a $43 million termination fee and $22 million incentive fee resulting from the termination of the Company’s management agreement with NRE. |
(3) | During the third quarter 2019, the Company’s Consolidated Statement of Operations included approximately $26 million of one-time compensation costs, which represent the acceleration of NRE equity awards held by certain employees and other cash compensation paid by NRE to certain employees. The full amount of these compensation costs were paid by NRE; as a result, a corresponding $26 million offset was recorded in Other Income. In addition, the Company was responsible for severance payments to certain employees dedicated to NRE’s business of $13 million, which was added back to the Company's net loss to calculate Core FFO. |
(4) | Net loss included $53 million of accelerated amortization of investment management intangibles related to the termination of NRE’s management agreement which is added back to the Company's net loss to calculate Core FFO. |
(5) | Represents a $387 million reduction to goodwill as a result of the pending sale of the Industrial platform and real estate portfolio and the decrease in management fees from CLNC resulting from its reduced fee base, in connection with its portfolio bifurcation. The reduction of goodwill is added back to the Company's net loss to calculate Core FFO. |
(6) | Net loss included a $51 million gain from the remeasurement of our 50% interest in the manager of the $4 billion Digital Colony Partners fund resulting from the acquisition of DBH. The remeasurement gain is excluded in the calculation of Core FFO. |
(7) | As of September 30, 2019, the Company's light industrial portfolio and related operating platform were under contract for sale. Accordingly, for all current and prior periods presented, the related operating results are presented as income from discontinued operations on the consolidated statement of operations. During the third quarter 2019, the Company recognized a net $18 million of unrealized carried interest accrual related to the anticipated sale of the industrial portfolio. |
Colony Capital | Supplemental Financial Report | 45 |
Xb. Investment Management – Assets Under Management |
($ in millions, except as noted; as of September 30, 2019, unless otherwise noted) | |||||||||||||||
Segment | Products (FEEUM) | Description | AUM CLNY OP Share | FEEUM CLNY OP Share | Fee Rate | ||||||||||
Digital Infrastructure | • Digital Bridge Holdings ($7.1 billion) | • Leading global investment manager of digital infrastructure assets including cell towers, small cells, fiber and data centers • Manages and operates nine global portfolio companies | $ | 13,796 | $ | 7,082 | 1.0 | % | |||||||
Institutional Funds | • Credit ($2.4 billion) • Core plus / value-added ($0.1 billion) • Opportunistic ($0.5 billion) • Colony Industrial ($2.1 billion) • Colony Latam Partners ($0.5 billion) • Other co-investment vehicles ($1.4 billion) | • 27 years of institutional investment management experience • Sponsorship of private equity funds and vehicles earning asset management fees and performance fees • More than 300 investor relationships • Colony Industrial Open-End Fund | 10,601 | 7,021 | .8 | % | |||||||||
Public Company | • Colony Credit Real Estate, Inc. ($3.0 billion) | • NYSE-listed credit focused REIT • Contract with base management fees with potential for incentive fees | 3,522 | 3,010 | (1) | 1.5 | % | ||||||||
Retail Companies | • NorthStar Healthcare ($1.3 billion)(2) • CC Real Estate Income Funds(3)(4) | • Manage public non-traded vehicles earning asset management and performance fees | 3,440 | 1,364 | (2) | 1.5 | % | ||||||||
Non-Wholly Owned REIM Platforms | • RXR Realty • American Healthcare Investors • Hamburg Trust | • CLNY recognizes at-share earnings from underlying non-wholly owned REIM platforms • 27% investment in RXR Realty, a real estate owner, developer and investment management company with $20 billion of AUM • 43% investment in American Healthcare Investors, a healthcare investment management firm and sponsor of non-traded vehicles with $3 billion of AUM | 7,952 | 3,934 | N/A | ||||||||||
Total | $ | 39,311 | $ | 22,411 |
(1) | Subsequent to the third quarter 2019, the Company and CLNC revised the terms of the management agreement in connection with CLNC's portfolio bifurcation and related impairments, which will result in the reduction of the fee base by accumulated unrealized provisions for loan losses and real estate impairments. Such reduction will be effective during the fourth quarter 2019 and result in the decrease of the Company's FEEUM to $2.2 billion. |
(2) | FEEUM of NorthStar Healthcare Income represents its most recently published Net Asset Value. |
(3) | CC Real Estate Income Funds represents a master/feeder structure and pools investor capital raised through three feeder funds. |
(4) | In February 2019, the board of directors of CC Real Estate Income Fund approved a plan to dissolve, liquidate and terminate CCREIF and distribute the net proceeds of such liquidation to its shareholders. There is no assurances to the timing or completion of the liquidation. |
Colony Capital | Supplemental Financial Report | 46 |
Colony Capital | Supplemental Financial Report | 47 |
XIa. Appendices - Definitions |
Colony Capital | Supplemental Financial Report | 48 |
XIa. Appendices - Definitions |
Colony Capital | Supplemental Financial Report | 49 |
XIb. Appendices - Reconciliation of Net Income (Loss) to NOI |
($ in thousands; for the three months ended September 30, 2019) | ||||||||||||||||
NOI Determined as Follows | Healthcare | Industrial | Hospitality | Other Equity and Debt—Net Lease Properties | ||||||||||||
Total revenues | $ | 136,091 | $ | 98,642 | $ | 218,378 | $ | 3,286 | ||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | 1,235 | (4,518 | ) | 314 | (885 | ) | ||||||||||
Interest income | — | (240 | ) | — | — | |||||||||||
Other income | — | — | (69 | ) | — | |||||||||||
Property operating expenses(1) | (66,042 | ) | (26,051 | ) | (141,235 | ) | (1,309 | ) | ||||||||
Compensation and administrative expense(1) | — | (1,042 | ) | — | — | |||||||||||
NOI(2) | $ | 71,284 | $ | 66,791 | $ | 77,388 | $ | 1,092 | ||||||||
Reconciliation of Net Income (Loss) from Continuing Operations to NOI | ||||||||||||||||
Healthcare | Industrial | Hospitality | ||||||||||||||
Income (loss) | $ | (112,554 | ) | $ | 38,981 | $ | (34,365 | ) | ||||||||
Adjustments: | ||||||||||||||||
Straight-line rent revenue and amortization of above- and below-market lease intangibles | 1,235 | (4,518 | ) | 314 | ||||||||||||
Interest income | — | (240 | ) | — | ||||||||||||
Interest expense | 46,029 | 21,130 | 40,641 | |||||||||||||
Transaction, investment and servicing costs | 1,009 | 54 | 1,728 | |||||||||||||
Depreciation and amortization | 38,998 | 12,342 | 36,133 | |||||||||||||
Impairment loss | 92,885 | — | 31,555 | |||||||||||||
Compensation and administrative expense | 2,537 | 3,832 | 1,658 | |||||||||||||
Gain on sale of real estate | (833 | ) | (4,675 | ) | — | |||||||||||
Other (gain) loss, net | 2,544 | 12 | 37 | |||||||||||||
Other income | — | — | (69 | ) | ||||||||||||
Income tax (benefit) expense | (566 | ) | (127 | ) | (244 | ) | ||||||||||
NOI(2) | $ | 71,284 | $ | 66,791 | $ | 77,388 |
(1) | For healthcare and hospitality, property operating expenses includes property management fees paid to third parties. For industrial, there are direct costs of managing the portfolio which are included in compensation expense. |
(2) | For hospitality, NOI is before FF&E Reserve. |
Colony Capital | Supplemental Financial Report | 50 |
XIb. Appendices - Reconciliation of Net Income (Loss) to NOI (cont’d) |
($ in thousands; for the three months ended September 30, 2019) | ||||
Reconciliation of Net Income from Continuing Operations of Other Equity and Debt Segment to NOI of Net Lease Real Estate Equity | ||||
Other Equity and Debt | ||||
Income from continuing operations | $ | (5,160 | ) | |
Adjustments: | ||||
Property operating income of other real estate equity | (105,587 | ) | ||
Straight-line rent revenue and amortization of above- and below-market lease intangibles for net lease real estate equity | (885 | ) | ||
Interest income | (38,734 | ) | ||
Fee and other income | (3,530 | ) | ||
Property operating expense of other real estate equity | 65,765 | |||
Interest expense | 27,428 | |||
Transaction, investment and servicing costs | 8,211 | |||
Depreciation and amortization | 17,152 | |||
Provision for loan loss | 17,233 | |||
Impairment loss | 53,459 | |||
Compensation and administrative expense | 5,904 | |||
Gain on sale of real estate assets | (7,391 | ) | ||
Other loss, net | 1,709 | |||
Earnings of investments in unconsolidated ventures | (35,587 | ) | ||
Income tax expense | 1,105 | |||
NOI of net lease real estate equity | $ | 1,092 |
Colony Capital | Supplemental Financial Report | 51 |
XIc. Appendices - Industrial Real Estate Segment Held For Sale |
($ in thousands, except per share data) (unaudited) | As of September 30, 2019 | |||
Assets | ||||
Restricted cash | 3,267 | |||
Real estate, net | 4,240,742 | |||
Goodwill | 20,000 | |||
Deferred leasing costs and intangible assets, net | 148,518 | |||
Other assets | 75,015 | |||
Total assets | $ | 4,487,542 | ||
Liabilities | ||||
Debt, net | $ | 2,131,497 | ||
Accrued and other liabilities | 108,041 | |||
Intangible liabilities, net | 12,577 | |||
Total liabilities | 2,252,115 |
Colony Capital | Supplemental Financial Report | 52 |
XIc. Appendices - Industrial Real Estate Segment Discontinued Operations |
($ in thousands) (unaudited) | Three Months Ended September 30, 2019 | |||
Revenues | ||||
Property operating income | $ | 97,188 | ||
Interest income | 240 | |||
Other income | 1,214 | |||
Total revenues | 98,642 | |||
Expenses | ||||
Property operating expense | 26,051 | |||
Interest expense | 21,130 | |||
Investment and servicing expense | 54 | |||
Depreciation and amortization | 12,342 | |||
Compensation expense | ||||
Cash and equity-based compensation | 3,914 | |||
Administrative expenses | 960 | |||
Total expenses | 64,451 | |||
Other income (loss) | ||||
Gain on sale of real estate assets | 4,675 | |||
Other gain (loss), net | (12 | ) | ||
Income (loss) before income taxes | 38,854 | |||
Income tax benefit (expense) | 127 | |||
Income (loss) from continuing operations | 38,981 | |||
Net income (loss) | 38,981 | |||
Net income (loss) attributable to noncontrolling interests: | ||||
Investment entities | 27,728 | |||
Operating Company | 990 | |||
Net income (loss) attributable to Colony Capital, Inc. | 10,263 | |||
Net income (loss) attributable to common stockholders | $ | 10,263 |
Colony Capital | Supplemental Financial Report | 53 |